data_2l07_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l07 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.792 0.33 . . . . 71.510000000000005 110.954 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.5 p -93.73 130.85 42.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.26 -0.427 . . . . 71.140000000000001 111.134 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -99.26 160.5 27.42 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.627 0.727 . . . . 72.219999999999999 110.925 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -19.53 36.0 Favored 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.697 2.264 . . . . 74.450000000000003 112.376 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -68.63 -19.65 64.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 63.130000000000003 110.924 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.21 6.01 36.98 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.716 -0.754 . . . . 72.340000000000003 112.512 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 t -116.1 168.97 9.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.866 0.365 . . . . 71.340000000000003 110.851 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 23.0 pt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.068 -0.515 . . . . 74.439999999999998 111.087 -179.996 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.4 mtpt . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.817 0.341 . . . . 75.120000000000005 110.886 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -83.13 125.26 40.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 72.549999999999997 111.15 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -97.95 160.51 28.27 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.67 0.748 . . . . 74.310000000000002 110.919 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 -18.99 37.15 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.705 2.27 . . . . 75.430000000000007 112.354 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -70.17 -19.68 63.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 73.0 110.873 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.1 6.1 37.18 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.726 -0.749 . . . . 74.549999999999997 112.476 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 t -117.79 173.73 6.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.892 0.377 . . . . 63.439999999999998 110.813 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 20.4 pt . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 71.030000000000001 111.119 179.977 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.863 0.363 . . . . 71.230000000000004 110.901 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.5 t -76.96 124.53 35.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 73.150000000000006 111.159 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -98.16 160.6 27.91 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.673 0.749 . . . . 74.310000000000002 110.879 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -19.01 36.7 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.716 2.277 . . . . 54.549999999999997 112.259 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -69.78 -19.64 63.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.427 . . . . 73.129999999999995 110.901 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.09 6.13 37.17 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.744 -0.741 . . . . 71.400000000000006 112.52 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 t -117.14 171.57 7.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.9 0.381 . . . . 74.120000000000005 110.818 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 21.9 pt . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 74.540000000000006 111.114 179.978 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.7 tttp . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.789 0.328 . . . . 75.510000000000005 110.964 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.8 t -88.44 129.18 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 74.129999999999995 111.179 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -98.97 160.6 27.32 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.707 0.765 . . . . 74.420000000000002 110.906 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -19.03 36.62 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.657 2.238 . . . . 74.430000000000007 112.373 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -69.32 -19.61 63.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 75.319999999999993 110.827 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.05 6.1 37.31 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.73 -0.748 . . . . 64.239999999999995 112.479 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.2 t -117.15 171.08 8.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.854 0.359 . . . . 60.149999999999999 110.853 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.8 mp . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 64.430000000000007 111.113 179.925 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.836 0.351 . . . . 75.25 110.909 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p -88.3 128.76 40.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.439 . . . . 75.129999999999995 111.087 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -99.1 160.65 27.13 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.623 0.725 . . . . 74.239999999999995 110.927 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 -19.08 36.22 Favored 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.651 2.234 . . . . 73.349999999999994 112.337 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -69.21 -19.69 63.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 61.530000000000001 110.87 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.15 6.08 37.06 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.77 -0.729 . . . . 72.450000000000003 112.48 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.2 t -117.13 171.11 8.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.853 0.358 . . . . 75.329999999999998 110.878 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 17.0 pt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 74.099999999999994 111.096 179.938 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.809 0.338 . . . . 75.430000000000007 110.924 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.3 t -88.02 134.12 28.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 73.450000000000003 111.087 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -97.98 160.61 27.99 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.693 0.759 . . . . 73.200000000000003 110.947 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.74 -18.71 36.96 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.706 2.271 . . . . 75.239999999999995 112.37 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -70.13 -19.65 63.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 75.109999999999999 110.925 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.13 6.08 37.12 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.697 -0.763 . . . . 75.310000000000002 112.504 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.7 t -116.06 169.11 9.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.811 0.338 . . . . 62.140000000000001 110.845 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 25.7 mm . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 72.219999999999999 111.149 179.909 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.5 ttpp . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.814 0.34 . . . . 74.120000000000005 110.92 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.4 t -88.08 134.94 26.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 72.140000000000001 111.147 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -99.53 160.6 27.0 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.653 0.74 . . . . 71.420000000000002 110.944 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -20.06 35.3 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.715 2.276 . . . . 74.239999999999995 112.297 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -68.02 -19.73 64.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 71.120000000000005 110.887 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.14 6.16 37.01 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.742 -0.742 . . . . 71.409999999999997 112.455 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.2 t -115.87 168.7 9.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.868 0.366 . . . . 73.540000000000006 110.874 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 62.4 mt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 74.400000000000006 111.064 179.978 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.6 mtpt . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.849 0.357 . . . . 74.340000000000003 110.924 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.5 t -90.58 131.42 37.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 74.049999999999997 111.178 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -99.76 160.65 26.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.738 0.78 . . . . 75.430000000000007 110.928 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 -19.83 35.24 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.67 2.247 . . . . 75.040000000000006 112.37 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -68.11 -19.67 64.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 73.409999999999997 110.86 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.08 6.16 37.16 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.805 -0.712 . . . . 60.119999999999997 112.458 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 t -116.0 168.67 9.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.87 0.367 . . . . 73.0 110.817 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 58.4 mt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.089 -0.505 . . . . 74.409999999999997 111.111 179.927 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.873 0.368 . . . . 75.219999999999999 110.911 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.8 p -87.77 131.06 36.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.207 -0.451 . . . . 74.409999999999997 111.143 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -99.65 160.56 27.06 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.661 0.744 . . . . 63.310000000000002 110.908 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.85 -19.45 35.69 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.629 2.219 . . . . 74.450000000000003 112.299 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -68.73 -19.62 64.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.246 -0.434 . . . . 65.310000000000002 110.845 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.13 6.07 37.13 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.665 -0.779 . . . . 71.439999999999998 112.514 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 t -116.4 169.93 8.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.361 . . . . 71.230000000000004 110.935 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 16.3 pt . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.17 -0.468 . . . . 75.430000000000007 111.176 179.962 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 11.1 tptm . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.764 0.316 . . . . 73.219999999999999 110.916 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.2 t -90.89 129.26 41.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 63.119999999999997 111.147 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -98.58 160.5 27.85 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.762 0.791 . . . . 74.049999999999997 110.878 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -19.59 35.95 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.748 2.299 . . . . 73.439999999999998 112.354 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -69.04 -19.59 64.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.456 . . . . 71.329999999999998 110.798 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.11 6.0 37.26 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.701 -0.761 . . . . 74.209999999999994 112.457 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.6 t -115.57 169.03 9.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.9 0.381 . . . . 62.240000000000002 110.869 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.0 mp . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 63.229999999999997 111.164 179.935 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.857 0.36 . . . . 63.109999999999999 110.884 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.4 p -87.51 132.45 32.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.445 . . . . 65.430000000000007 111.15 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -99.04 160.53 27.47 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.668 0.747 . . . . 73.329999999999998 110.891 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -19.46 36.24 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.657 2.238 . . . . 74.319999999999993 112.344 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -68.89 -19.53 64.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.254 -0.43 . . . . 74.349999999999994 110.834 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.04 6.11 37.34 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.725 -0.75 . . . . 51.0 112.522 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 t -115.81 168.65 9.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.88 0.372 . . . . 73.129999999999995 110.832 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 41.8 mm . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 74.239999999999995 111.115 179.976 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.813 0.339 . . . . 71.340000000000003 110.915 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.6 p -97.53 134.3 36.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 72.420000000000002 111.099 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -99.98 160.6 26.77 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.705 0.764 . . . . 75.319999999999993 110.91 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -19.88 35.5 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.684 2.256 . . . . 73.109999999999999 112.335 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -68.05 -19.6 64.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 61.399999999999999 110.842 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.19 5.98 37.07 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.696 -0.764 . . . . 60.340000000000003 112.475 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.0 t -115.07 167.09 11.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.852 0.358 . . . . 72.319999999999993 110.876 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 62.8 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.484 . . . . 74.340000000000003 111.091 179.905 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.827 0.346 . . . . 73.409999999999997 110.889 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.4 t -95.03 131.42 41.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.445 . . . . 63.210000000000001 111.159 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -99.48 160.63 26.95 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.597 0.713 . . . . 74.209999999999994 110.975 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.85 -20.08 34.88 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.733 2.289 . . . . 61.229999999999997 112.312 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -68.25 -19.56 64.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 71.239999999999995 110.843 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.06 6.17 37.21 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.781 -0.724 . . . . 74.430000000000007 112.49 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 t -114.65 167.01 11.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.858 0.361 . . . . 74.319999999999993 110.871 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.5 mp . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.46 . . . . 71.150000000000006 111.141 179.905 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.824 0.345 . . . . 75.510000000000005 110.943 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.0 t -90.42 132.11 35.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 72.109999999999999 111.1 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -98.03 160.54 28.13 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.697 0.761 . . . . 71.409999999999997 110.939 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 -20.89 34.19 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.735 2.29 . . . . 75.319999999999993 112.364 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -68.19 -19.55 64.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 71.450000000000003 110.881 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.12 6.07 37.16 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.719 -0.753 . . . . 63.109999999999999 112.438 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.6 t -114.19 168.08 10.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.91 0.386 . . . . 71.019999999999996 110.867 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 25.3 mm . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.119 -0.492 . . . . 75.430000000000007 111.102 179.923 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.5 ttmm . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.867 0.365 . . . . 74.129999999999995 110.881 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.9 p -102.35 131.31 50.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 74.310000000000002 111.163 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -98.35 160.5 28.01 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.632 0.729 . . . . 74.420000000000002 110.962 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -20.19 35.25 Favored 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.696 2.264 . . . . 75.439999999999998 112.417 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -68.6 -19.42 64.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 74.129999999999995 110.901 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.07 6.11 37.26 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.743 -0.741 . . . . 73.319999999999993 112.489 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.5 t -114.62 167.32 10.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.842 0.353 . . . . 71.319999999999993 110.817 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.1 pt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 74.430000000000007 111.178 179.915 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.9 ttmt . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.809 0.338 . . . . 73.019999999999996 110.89 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.7 p -89.12 129.98 39.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 70.109999999999999 111.111 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -99.72 160.56 27.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.684 0.754 . . . . 74.239999999999995 110.95 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -19.89 35.66 Favored 'Trans proline' 0 C--N 1.34 0.115 0 C-N-CA 122.69 2.26 . . . . 74.329999999999998 112.335 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -68.34 -19.45 64.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 64.099999999999994 110.842 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.09 6.14 37.16 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 73.310000000000002 112.45 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.6 t -114.87 166.68 11.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.824 0.345 . . . . 72.319999999999993 110.859 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.6 mp . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 72.239999999999995 111.134 179.959 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 52.0 mttt . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.779 0.323 . . . . 72.519999999999996 110.913 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -94.57 131.34 41.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 72.209999999999994 111.146 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -99.69 160.66 26.76 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.707 0.765 . . . . 72.329999999999998 110.934 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.84 -19.29 35.93 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.658 2.239 . . . . 74.239999999999995 112.367 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -68.56 -19.47 64.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 71.409999999999997 110.939 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.06 6.12 37.26 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.779 -0.724 . . . . 65.109999999999999 112.523 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.2 t -114.28 164.62 13.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.915 0.388 . . . . 74.219999999999999 110.777 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.2 mp . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 74.540000000000006 111.097 179.958 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.4 mttp . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.834 0.35 . . . . 73.329999999999998 110.919 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.4 t -92.96 132.4 37.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 74.219999999999999 111.1 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -99.74 160.57 26.98 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.618 0.723 . . . . 75.040000000000006 110.965 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -19.98 35.53 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.653 2.235 . . . . 73.519999999999996 112.292 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 -68.09 -19.53 64.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 72.030000000000001 110.852 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.16 6.12 36.98 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 64.030000000000001 112.453 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 t -113.78 164.76 13.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.798 0.333 . . . . 73.329999999999998 110.85 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 55.6 mt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 75.129999999999995 111.112 179.937 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 31.3 tttt . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.823 0.345 . . . . 73.219999999999999 110.944 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -105.22 132.79 51.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 75.409999999999997 111.106 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -99.98 160.6 26.77 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.656 0.741 . . . . 74.030000000000001 110.953 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 -19.77 35.41 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.697 2.265 . . . . 74.439999999999998 112.322 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -68.04 -19.47 64.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 74.340000000000003 110.939 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.06 6.09 37.29 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.778 -0.725 . . . . 73.430000000000007 112.504 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 t -114.39 165.32 12.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.898 0.38 . . . . 73.450000000000003 110.815 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 29.0 pt . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.123 -0.489 . . . . 63.130000000000003 111.05 179.987 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.834 0.35 . . . . 74.239999999999995 110.905 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.9 p -97.32 136.74 27.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.295 -0.411 . . . . 75.439999999999998 111.147 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -100.0 160.59 26.8 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.717 0.77 . . . . 75.109999999999999 110.922 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -19.77 35.81 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.642 2.228 . . . . 72.129999999999995 112.411 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -68.06 -19.5 64.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 74.430000000000007 110.877 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.12 6.0 37.23 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.747 -0.739 . . . . 71.299999999999997 112.531 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.9 t -113.8 164.28 13.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.876 0.37 . . . . 61.399999999999999 110.836 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 31.6 mt . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 75.319999999999993 111.135 179.969 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.838 0.351 . . . . 64.329999999999998 110.829 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 11.4 m -129.21 162.13 28.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 71.120000000000005 110.934 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.5 tppt? -142.16 123.48 14.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 73.019999999999996 110.889 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -59.19 133.15 55.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 55.109999999999999 110.86 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -88.68 127.21 35.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.457 . . . . 71.510000000000005 110.954 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.5 p -93.73 130.85 42.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.26 -0.427 . . . . 71.140000000000001 111.134 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -99.26 160.5 27.42 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.627 0.727 . . . . 72.219999999999999 110.925 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -19.53 36.0 Favored 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.697 2.264 . . . . 74.450000000000003 112.376 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -68.63 -19.65 64.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 63.130000000000003 110.924 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.21 6.01 36.98 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.716 -0.754 . . . . 72.340000000000003 112.512 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 t -116.1 168.97 9.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.866 0.365 . . . . 71.340000000000003 110.851 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 23.0 pt -115.54 148.3 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.068 -0.515 . . . . 74.439999999999998 111.087 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.0 t -99.12 133.87 42.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.481 . . . . 62.539999999999999 110.839 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -99.17 61.06 1.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 71.519999999999996 110.866 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -148.13 116.88 6.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 74.400000000000006 110.904 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.1 t -113.13 144.61 42.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 65.319999999999993 110.902 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -87.18 133.68 33.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 73.319999999999993 110.857 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 13.7 p90 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 71.430000000000007 110.859 -179.802 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.6 t70 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.846 0.355 . . . . 64.109999999999999 110.848 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 5.8 t -129.19 150.14 50.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 73.030000000000001 110.887 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -113.68 114.9 27.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 75.120000000000005 110.833 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -58.94 128.63 38.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 75.150000000000006 110.829 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.4 mtpt -91.22 122.19 33.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 75.120000000000005 110.886 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -83.13 125.26 40.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 72.549999999999997 111.15 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -97.95 160.51 28.27 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.67 0.748 . . . . 74.310000000000002 110.919 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 -18.99 37.15 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.705 2.27 . . . . 75.430000000000007 112.354 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -70.17 -19.68 63.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 73.0 110.873 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.1 6.1 37.18 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.726 -0.749 . . . . 74.549999999999997 112.476 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 t -117.79 173.73 6.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.892 0.377 . . . . 63.439999999999998 110.813 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 20.4 pt -108.87 154.84 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 71.030000000000001 111.119 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 t -63.04 136.66 57.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 64.540000000000006 110.819 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -106.72 51.91 0.73 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.08 -0.509 . . . . 74.340000000000003 110.855 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -164.88 142.47 6.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 73.299999999999997 110.891 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 m -147.02 139.2 24.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.106 -0.497 . . . . 74.120000000000005 110.86 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -130.78 148.58 52.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 75.310000000000002 110.929 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 72.340000000000003 110.889 -179.89 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.838 0.351 . . . . 75.329999999999998 110.856 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 45.2 t -134.15 140.11 46.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 73.219999999999999 110.858 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -81.45 120.09 24.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.125 -0.489 . . . . 72.510000000000005 110.89 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 35.0 ptt85 -54.01 137.62 39.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 72.329999999999998 110.888 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -99.13 114.22 26.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 71.230000000000004 110.901 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.5 t -76.96 124.53 35.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 73.150000000000006 111.159 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -98.16 160.6 27.91 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.673 0.749 . . . . 74.310000000000002 110.879 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -19.01 36.7 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.716 2.277 . . . . 54.549999999999997 112.259 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -69.78 -19.64 63.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.427 . . . . 73.129999999999995 110.901 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.09 6.13 37.17 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.744 -0.741 . . . . 71.400000000000006 112.52 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 t -117.14 171.57 7.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.9 0.381 . . . . 74.120000000000005 110.818 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 21.9 pt -110.92 140.87 28.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 74.540000000000006 111.114 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.3 t -61.71 176.93 0.46 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 71.219999999999999 110.851 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -134.08 -43.84 0.79 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.501 . . . . 74.5 110.886 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -89.0 147.34 24.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 71.019999999999996 110.98 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 82.9 m -121.29 166.62 13.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 75.230000000000004 110.879 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -105.27 136.98 43.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 62.240000000000002 110.886 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 64.319999999999993 110.952 -179.903 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.798 0.332 . . . . 75.420000000000002 110.86 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 30.9 p -116.57 157.45 25.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 72.120000000000005 110.922 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.43 148.54 52.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 72.329999999999998 110.85 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 53.3 mtt85 -60.3 157.0 14.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 73.209999999999994 110.844 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.7 tttp -129.97 130.65 45.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 75.510000000000005 110.964 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.8 t -88.44 129.18 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 74.129999999999995 111.179 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -98.97 160.6 27.32 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.707 0.765 . . . . 74.420000000000002 110.906 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -19.03 36.62 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.657 2.238 . . . . 74.430000000000007 112.373 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -69.32 -19.61 63.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 75.319999999999993 110.827 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.05 6.1 37.31 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.73 -0.748 . . . . 64.239999999999995 112.479 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.2 t -117.15 171.08 8.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.854 0.359 . . . . 60.149999999999999 110.853 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.8 mp -115.06 140.6 35.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 64.430000000000007 111.113 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.0 t -79.29 129.95 34.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 75.129999999999995 110.864 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -116.43 74.05 0.88 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.123 -0.489 . . . . 73.329999999999998 110.904 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -150.27 131.95 14.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.15 -0.477 . . . . 75.140000000000001 110.953 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.9 t -135.77 149.61 49.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 61.539999999999999 110.903 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -88.35 147.18 24.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 72.200000000000003 110.865 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 17.6 p90 . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 75.340000000000003 110.91 -179.879 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 . . . . . 0 C--O 1.232 0.171 0 CA-C-O 120.827 0.346 . . . . 75.310000000000002 110.888 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 43.7 t -137.07 143.57 42.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 75.219999999999999 110.906 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -72.75 140.35 47.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 74.200000000000003 110.978 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.56 130.17 55.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.314 -0.403 . . . . 72.420000000000002 110.871 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.22 122.17 23.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.261 -0.427 . . . . 75.25 110.909 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p -88.3 128.76 40.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.439 . . . . 75.129999999999995 111.087 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -99.1 160.65 27.13 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.623 0.725 . . . . 74.239999999999995 110.927 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 -19.08 36.22 Favored 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.651 2.234 . . . . 73.349999999999994 112.337 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -69.21 -19.69 63.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 61.530000000000001 110.87 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.15 6.08 37.06 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.77 -0.729 . . . . 72.450000000000003 112.48 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.2 t -117.13 171.11 8.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.853 0.358 . . . . 75.329999999999998 110.878 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 17.0 pt -112.29 154.17 13.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 74.099999999999994 111.096 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 t -56.89 178.58 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 72.439999999999998 110.867 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -111.69 -34.68 5.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 72.340000000000003 110.864 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -127.6 142.15 51.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.195 -0.457 . . . . 74.230000000000004 110.906 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.0 p -127.32 152.79 47.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 64.310000000000002 110.876 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -141.69 152.59 44.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 63.340000000000003 110.932 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 74.9 t80 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.178 -0.464 . . . . 74.530000000000001 110.974 -179.86 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.0 t70 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.886 0.374 . . . . 64.409999999999997 110.831 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 10.6 t -115.05 138.2 51.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 71.439999999999998 110.893 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -63.88 131.55 48.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 73.129999999999995 110.879 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.29 170.19 10.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 73.439999999999998 110.858 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -135.97 142.76 44.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.192 -0.458 . . . . 75.430000000000007 110.924 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.3 t -88.02 134.12 28.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 73.450000000000003 111.087 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -97.98 160.61 27.99 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.693 0.759 . . . . 73.200000000000003 110.947 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.74 -18.71 36.96 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.706 2.271 . . . . 75.239999999999995 112.37 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -70.13 -19.65 63.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 75.109999999999999 110.925 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.13 6.08 37.12 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.697 -0.763 . . . . 75.310000000000002 112.504 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.7 t -116.06 169.11 9.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.811 0.338 . . . . 62.140000000000001 110.845 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 25.7 mm -102.04 144.38 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 72.219999999999999 111.149 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.1 p -58.42 147.02 32.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.507 . . . . 61.25 110.905 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.44 41.93 3.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 64.430000000000007 110.912 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -143.51 153.4 42.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.435 . . . . 72.450000000000003 110.96 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.6 m -130.41 155.57 46.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 63.25 110.818 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -107.02 146.27 31.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.505 . . . . 74.450000000000003 110.885 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 6.7 t80 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 75.299999999999997 110.919 -179.88 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.846 0.355 . . . . 74.349999999999994 110.875 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.3 m -122.62 149.96 43.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 73.109999999999999 110.851 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.8 mttm -146.01 149.77 34.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 72.319999999999993 110.96 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -59.35 154.57 16.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 74.019999999999996 110.931 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.5 ttpp -138.46 131.84 30.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 74.120000000000005 110.92 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.4 t -88.08 134.94 26.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 72.140000000000001 111.147 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -99.53 160.6 27.0 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.653 0.74 . . . . 71.420000000000002 110.944 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -20.06 35.3 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.715 2.276 . . . . 74.239999999999995 112.297 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -68.02 -19.73 64.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 71.120000000000005 110.887 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.14 6.16 37.01 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.742 -0.742 . . . . 71.409999999999997 112.455 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.2 t -115.87 168.7 9.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.868 0.366 . . . . 73.540000000000006 110.874 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 62.4 mt -109.41 142.49 21.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 74.400000000000006 111.064 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.0 p -70.05 160.81 31.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 75.200000000000003 110.869 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -109.16 -43.76 4.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 71.109999999999999 110.903 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -105.19 166.91 10.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.087 -0.506 . . . . 74.129999999999995 110.951 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.1 p -114.77 154.48 28.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.115 -0.493 . . . . 73.120000000000005 110.904 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -139.75 143.06 36.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 72.519999999999996 110.909 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 70.7 t80 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.154 -0.475 . . . . 75.450000000000003 110.916 -179.84 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.863 0.363 . . . . 72.420000000000002 110.866 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 47.8 t -125.51 146.07 49.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 74.239999999999995 110.836 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 48.0 tttp -69.22 117.2 10.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 74.219999999999999 110.943 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -91.69 170.98 9.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 74.549999999999997 110.81 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.6 mtpt -123.94 135.15 53.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 74.340000000000003 110.924 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.5 t -90.58 131.42 37.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 74.049999999999997 111.178 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -99.76 160.65 26.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.738 0.78 . . . . 75.430000000000007 110.928 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 -19.83 35.24 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.67 2.247 . . . . 75.040000000000006 112.37 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -68.11 -19.67 64.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 73.409999999999997 110.86 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.08 6.16 37.16 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.805 -0.712 . . . . 60.119999999999997 112.458 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 t -116.0 168.67 9.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.87 0.367 . . . . 73.0 110.817 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 58.4 mt -115.95 143.53 25.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.089 -0.505 . . . . 74.409999999999997 111.111 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.5 t -58.4 149.01 25.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 73.209999999999994 110.901 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -92.38 -43.27 9.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 71.510000000000005 110.884 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -109.36 154.11 23.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 75.049999999999997 110.956 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.0 p -122.6 143.3 49.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 50.140000000000001 110.882 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -132.09 129.47 39.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 64.230000000000004 110.869 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 75.6 t80 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.104 -0.498 . . . . 73.340000000000003 110.889 -179.812 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.903 0.383 . . . . 72.120000000000005 110.877 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 2.7 m -118.39 167.91 11.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 74.129999999999995 110.847 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.84 120.71 11.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 74.040000000000006 110.884 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.5 ptp85 -52.51 103.44 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 74.340000000000003 110.85 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt -68.85 111.18 4.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 75.219999999999999 110.911 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.8 p -87.77 131.06 36.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.207 -0.451 . . . . 74.409999999999997 111.143 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -99.65 160.56 27.06 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.661 0.744 . . . . 63.310000000000002 110.908 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.85 -19.45 35.69 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.629 2.219 . . . . 74.450000000000003 112.299 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -68.73 -19.62 64.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.246 -0.434 . . . . 65.310000000000002 110.845 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.13 6.07 37.13 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.665 -0.779 . . . . 71.439999999999998 112.514 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 t -116.4 169.93 8.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.361 . . . . 71.230000000000004 110.935 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 16.3 pt -112.79 149.83 15.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.17 -0.468 . . . . 75.430000000000007 111.176 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.5 m -74.89 -177.0 3.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.295 -0.411 . . . . 70.099999999999994 110.841 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -118.48 -65.72 1.15 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.042 -0.526 . . . . 74.299999999999997 110.884 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -75.73 140.08 42.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.229 -0.441 . . . . 74.420000000000002 110.932 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.1 p -120.75 139.59 52.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 61.0 110.839 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -86.37 146.13 26.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.481 . . . . 72.109999999999999 110.899 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 33.2 p90 . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 74.420000000000002 110.967 -179.951 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 24.1 t0 . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.825 0.345 . . . . 71.209999999999994 110.811 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 63.4 m -133.88 144.33 48.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.448 . . . . 72.150000000000006 110.894 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.08 123.54 50.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 73.219999999999999 110.901 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 85.2 mtm-85 -88.23 98.93 11.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 71.549999999999997 110.883 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 11.1 tptm -95.28 128.97 42.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.45 . . . . 73.219999999999999 110.916 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.2 t -90.89 129.26 41.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 63.119999999999997 111.147 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -98.58 160.5 27.85 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.762 0.791 . . . . 74.049999999999997 110.878 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -19.59 35.95 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.748 2.299 . . . . 73.439999999999998 112.354 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -69.04 -19.59 64.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.456 . . . . 71.329999999999998 110.798 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.11 6.0 37.26 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.701 -0.761 . . . . 74.209999999999994 112.457 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.6 t -115.57 169.03 9.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.9 0.381 . . . . 62.240000000000002 110.869 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.0 mp -113.24 149.84 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 63.229999999999997 111.164 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.7 t -93.02 143.32 26.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 71.099999999999994 110.882 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -113.95 64.52 0.66 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.177 -0.465 . . . . 63.140000000000001 110.848 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -100.31 134.83 42.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 75.420000000000002 110.944 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 98.4 m -131.34 144.22 51.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.086 -0.506 . . . . 55.229999999999997 110.891 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -106.29 152.61 23.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 75.239999999999995 110.854 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 52.5 t80 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 74.329999999999998 110.942 -179.869 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.81 0.338 . . . . 71.319999999999993 110.89 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.0 p -138.93 149.54 44.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 63.520000000000003 110.882 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.8 mmtm -108.95 139.37 43.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.225 -0.443 . . . . 71.549999999999997 110.864 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -65.2 140.2 58.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 74.439999999999998 110.869 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? -103.87 124.89 49.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 63.109999999999999 110.884 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.4 p -87.51 132.45 32.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.445 . . . . 65.430000000000007 111.15 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -99.04 160.53 27.47 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.668 0.747 . . . . 73.329999999999998 110.891 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -19.46 36.24 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.657 2.238 . . . . 74.319999999999993 112.344 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -68.89 -19.53 64.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.254 -0.43 . . . . 74.349999999999994 110.834 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.04 6.11 37.34 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.725 -0.75 . . . . 51.0 112.522 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 t -115.81 168.65 9.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.88 0.372 . . . . 73.129999999999995 110.832 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 41.8 mm -111.26 145.85 16.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 74.239999999999995 111.115 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.7 t -81.69 146.69 29.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 74.340000000000003 110.904 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -114.89 41.45 2.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 73.239999999999995 110.862 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -122.42 147.56 46.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 71.209999999999994 110.958 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.8 m -141.47 147.86 38.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 70.209999999999994 110.865 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -106.69 121.11 43.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 63.229999999999997 110.866 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 41.3 p90 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 74.519999999999996 110.89 -179.843 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.883 0.373 . . . . 74.310000000000002 110.933 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 35.3 m -126.85 156.04 41.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 74.430000000000007 110.898 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 43.4 mmtt -112.09 137.41 50.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 72.239999999999995 110.924 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.5 ppt_? -74.76 167.6 21.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.42 . . . . 75.540000000000006 110.874 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -146.24 153.19 40.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 71.340000000000003 110.915 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.6 p -97.53 134.3 36.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 72.420000000000002 111.099 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -99.98 160.6 26.77 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.705 0.764 . . . . 75.319999999999993 110.91 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -19.88 35.5 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.684 2.256 . . . . 73.109999999999999 112.335 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -68.05 -19.6 64.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 61.399999999999999 110.842 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.19 5.98 37.07 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.696 -0.764 . . . . 60.340000000000003 112.475 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.0 t -115.07 167.09 11.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.852 0.358 . . . . 72.319999999999993 110.876 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 62.8 mt -114.57 144.8 21.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.484 . . . . 74.340000000000003 111.091 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.3 t -82.21 140.96 33.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 62.509999999999998 110.871 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -113.64 -31.48 6.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 73.549999999999997 110.902 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -84.98 159.64 20.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.212 -0.449 . . . . 73.510000000000005 110.917 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 36.5 t -124.94 131.5 53.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 74.109999999999999 110.896 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -121.33 152.54 38.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 74.049999999999997 110.904 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 50.3 p90 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.21 -0.45 . . . . 74.430000000000007 110.891 -179.966 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.84 0.352 . . . . 74.230000000000004 110.819 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.8 m -122.49 169.91 10.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.09 -0.505 . . . . 74.109999999999999 110.821 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.1 tttp -70.24 135.38 48.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.497 . . . . 71.150000000000006 110.938 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -107.93 144.02 35.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 74.010000000000005 110.875 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -118.09 126.39 52.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 73.409999999999997 110.889 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.4 t -95.03 131.42 41.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.445 . . . . 63.210000000000001 111.159 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -99.48 160.63 26.95 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.597 0.713 . . . . 74.209999999999994 110.975 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.85 -20.08 34.88 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.733 2.289 . . . . 61.229999999999997 112.312 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -68.25 -19.56 64.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 71.239999999999995 110.843 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.06 6.17 37.21 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.781 -0.724 . . . . 74.430000000000007 112.49 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 t -114.65 167.01 11.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.858 0.361 . . . . 74.319999999999993 110.871 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.28 145.47 23.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.46 . . . . 71.150000000000006 111.141 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.6 t -104.27 134.3 47.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 74.409999999999997 110.814 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -109.29 88.54 2.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.061 -0.518 . . . . 74.040000000000006 110.845 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -141.78 127.18 18.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 74.040000000000006 110.908 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.9 t -116.43 140.32 49.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 74.099999999999994 110.824 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -73.85 151.19 40.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 74.010000000000005 110.822 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 44.5 p90 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.144 -0.48 . . . . 74.409999999999997 110.933 -179.905 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.809 0.337 . . . . 74.319999999999993 110.91 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 16.6 t -132.37 144.26 50.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 65.420000000000002 110.836 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -79.19 148.56 32.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 75.409999999999997 110.927 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.12 137.26 48.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 71.219999999999999 110.912 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -125.8 133.37 52.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 75.510000000000005 110.943 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.0 t -90.42 132.11 35.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 72.109999999999999 111.1 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -98.03 160.54 28.13 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.697 0.761 . . . . 71.409999999999997 110.939 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 -20.89 34.19 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.735 2.29 . . . . 75.319999999999993 112.364 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -68.19 -19.55 64.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 71.450000000000003 110.881 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.12 6.07 37.16 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.719 -0.753 . . . . 63.109999999999999 112.438 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.6 t -114.19 168.08 10.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.91 0.386 . . . . 71.019999999999996 110.867 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 25.3 mm -107.82 146.26 14.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.119 -0.492 . . . . 75.430000000000007 111.102 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.5 m -67.34 121.08 14.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 70.219999999999999 110.832 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -91.61 -41.62 10.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.116 -0.493 . . . . 64.239999999999995 110.841 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -71.21 166.42 21.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 73.319999999999993 110.951 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 92.3 m -124.4 134.34 53.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 75.430000000000007 110.945 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -96.27 140.07 31.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 74.450000000000003 110.871 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.113 -0.494 . . . . 75.340000000000003 110.905 -179.86 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 34.3 t70 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.883 0.373 . . . . 73.239999999999995 110.92 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 44.0 t -150.43 134.75 17.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.437 . . . . 73.400000000000006 110.885 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -72.81 144.98 47.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 75.340000000000003 110.95 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 88.0 mtt180 -57.3 115.73 2.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 75.310000000000002 110.839 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.5 ttmm -67.22 133.03 48.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 74.129999999999995 110.881 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.9 p -102.35 131.31 50.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 74.310000000000002 111.163 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -98.35 160.5 28.01 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.632 0.729 . . . . 74.420000000000002 110.962 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -20.19 35.25 Favored 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.696 2.264 . . . . 75.439999999999998 112.417 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -68.6 -19.42 64.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 74.129999999999995 110.901 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.07 6.11 37.26 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.743 -0.741 . . . . 73.319999999999993 112.489 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.5 t -114.62 167.32 10.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.842 0.353 . . . . 71.319999999999993 110.817 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.1 pt -111.87 153.13 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 74.430000000000007 111.178 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.8 t -70.61 161.81 30.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 62.409999999999997 110.849 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -81.07 -53.12 6.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 74.430000000000007 110.827 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -136.2 174.63 10.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 72.230000000000004 110.874 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 13.9 t -121.79 125.89 47.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 74.430000000000007 110.849 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -68.15 145.06 54.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.096 -0.502 . . . . 75.010000000000005 110.919 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 13.1 t80 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.092 -0.504 . . . . 74.129999999999995 110.935 -179.851 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.857 0.36 . . . . 73.319999999999993 110.86 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 12.1 t -130.35 152.46 49.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 75.409999999999997 110.862 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -80.53 111.57 17.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 71.439999999999998 110.894 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.95 147.49 7.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 72.430000000000007 110.88 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.9 ttmt -105.26 115.33 30.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 73.019999999999996 110.89 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.7 p -89.12 129.98 39.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 70.109999999999999 111.111 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -99.72 160.56 27.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.684 0.754 . . . . 74.239999999999995 110.95 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -19.89 35.66 Favored 'Trans proline' 0 C--N 1.34 0.115 0 C-N-CA 122.69 2.26 . . . . 74.329999999999998 112.335 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -68.34 -19.45 64.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 64.099999999999994 110.842 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.09 6.14 37.16 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 73.310000000000002 112.45 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.6 t -114.87 166.68 11.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.824 0.345 . . . . 72.319999999999993 110.859 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.6 mp -118.45 138.26 49.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 72.239999999999995 111.134 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.3 t -94.78 128.12 41.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 60.030000000000001 110.873 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -93.66 60.3 2.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.486 . . . . 73.019999999999996 110.839 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -137.44 152.76 49.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 75.310000000000002 110.921 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 16.3 t -135.21 129.99 34.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 71.519999999999996 110.895 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -61.82 137.19 58.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 70.120000000000005 110.796 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 36.9 p90 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 74.430000000000007 110.996 -179.92 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 . . . . . 0 N--CA 1.457 -0.093 0 CA-C-O 120.86 0.362 . . . . 64.329999999999998 110.905 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 34.9 m -122.96 145.29 48.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 71.319999999999993 110.895 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -81.18 126.36 31.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.465 . . . . 64.439999999999998 110.875 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -88.12 131.85 34.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.291 -0.413 . . . . 74.409999999999997 110.889 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -138.82 137.16 36.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 72.519999999999996 110.913 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -94.57 131.34 41.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 72.209999999999994 111.146 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -99.69 160.66 26.76 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.707 0.765 . . . . 72.329999999999998 110.934 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.84 -19.29 35.93 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.658 2.239 . . . . 74.239999999999995 112.367 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -68.56 -19.47 64.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 71.409999999999997 110.939 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.06 6.12 37.26 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.779 -0.724 . . . . 65.109999999999999 112.523 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.2 t -114.28 164.62 13.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.915 0.388 . . . . 74.219999999999999 110.777 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.2 mp -119.25 143.23 31.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 74.540000000000006 111.097 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.4 m -69.75 116.74 10.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 73.349999999999994 110.807 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -83.61 -64.63 1.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.081 -0.509 . . . . 62.520000000000003 110.827 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -89.6 156.86 18.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 74.349999999999994 110.912 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.7 p -118.3 144.4 45.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 55.420000000000002 110.94 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -77.76 143.49 37.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 74.310000000000002 110.961 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 33.4 p90 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 74.129999999999995 110.886 -179.799 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.861 0.362 . . . . 61.039999999999999 110.826 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 7.5 p -119.91 159.48 24.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 72.129999999999995 110.848 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -63.17 122.7 16.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 75.409999999999997 110.875 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -69.56 110.53 4.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 75.030000000000001 110.873 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.4 mttp -76.95 116.73 17.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 73.329999999999998 110.919 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.4 t -92.96 132.4 37.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 74.219999999999999 111.1 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -99.74 160.57 26.98 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.618 0.723 . . . . 75.040000000000006 110.965 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -19.98 35.53 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.653 2.235 . . . . 73.519999999999996 112.292 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 -68.09 -19.53 64.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 72.030000000000001 110.852 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.16 6.12 36.98 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 64.030000000000001 112.453 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 t -113.78 164.76 13.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.798 0.333 . . . . 73.329999999999998 110.85 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 55.6 mt -117.64 144.07 26.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 75.129999999999995 111.112 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 m -103.0 129.46 49.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.482 . . . . 75.129999999999995 110.863 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -110.8 39.03 2.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.078 -0.51 . . . . 72.209999999999994 110.832 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -120.86 103.99 9.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.45 . . . . 64.450000000000003 110.916 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.1 p -127.22 130.78 50.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 73.430000000000007 110.867 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -63.04 125.15 23.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.104 -0.498 . . . . 62.140000000000001 110.889 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.6 p90 . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 116.179 -0.464 . . . . 73.25 110.969 -179.897 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.85 0.357 . . . . 64.409999999999997 110.822 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 24.5 m -140.79 144.54 35.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 74.299999999999997 110.857 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.5 ptmm? -114.52 127.85 56.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 73.420000000000002 110.877 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 86.2 mtm180 -74.76 119.51 19.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 73.340000000000003 110.902 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 31.3 tttt -69.12 142.28 54.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.44 . . . . 73.219999999999999 110.944 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -105.22 132.79 51.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 75.409999999999997 111.106 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -99.98 160.6 26.77 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.656 0.741 . . . . 74.030000000000001 110.953 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 -19.77 35.41 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.697 2.265 . . . . 74.439999999999998 112.322 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -68.04 -19.47 64.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 74.340000000000003 110.939 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.06 6.09 37.29 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.778 -0.725 . . . . 73.430000000000007 112.504 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 t -114.39 165.32 12.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.898 0.38 . . . . 73.450000000000003 110.815 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 29.0 pt -116.24 156.14 17.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.123 -0.489 . . . . 63.130000000000003 111.05 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.3 t -121.38 167.36 12.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.139 -0.482 . . . . 74.230000000000004 110.933 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -112.34 91.3 3.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.179 -0.464 . . . . 73.530000000000001 110.798 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -130.89 154.14 48.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 73.430000000000007 110.882 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 61.7 m -124.75 129.58 50.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.113 -0.494 . . . . 54.43 110.886 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -102.16 146.1 28.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 75.010000000000005 110.9 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.1 p90 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.234 -0.439 . . . . 75.25 110.92 -179.9 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.3 t70 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.871 0.367 . . . . 75.109999999999999 110.885 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 30.9 t -135.31 143.97 46.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 71.510000000000005 110.875 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -91.8 115.85 28.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 72.219999999999999 110.833 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 78.5 mtm-85 -59.65 131.36 50.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 75.129999999999995 110.839 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -105.9 132.22 52.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 74.239999999999995 110.905 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.9 p -97.32 136.74 27.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.295 -0.411 . . . . 75.439999999999998 111.147 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -100.0 160.59 26.8 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.717 0.77 . . . . 75.109999999999999 110.922 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -19.77 35.81 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.642 2.228 . . . . 72.129999999999995 112.411 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -68.06 -19.5 64.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 74.430000000000007 110.877 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.12 6.0 37.23 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.747 -0.739 . . . . 71.299999999999997 112.531 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.9 t -113.8 164.28 13.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.876 0.37 . . . . 61.399999999999999 110.836 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 31.6 mt -112.25 137.95 43.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 75.319999999999993 111.135 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.9 t -57.04 149.11 19.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 64.120000000000005 110.832 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -106.38 -38.22 6.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.511 . . . . 63.399999999999999 110.876 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -119.23 138.48 52.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 70.439999999999998 110.935 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 6.1 p -133.55 159.72 39.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.112 -0.495 . . . . 64.140000000000001 110.932 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -94.33 141.57 28.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 75.450000000000003 110.914 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 35.9 t80 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.143 -0.48 . . . . 72.519999999999996 110.933 -179.861 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.792 0.33 . . . . 71.51 110.954 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.5 p -93.73 130.85 42.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.26 -0.427 . . . . 71.04 111.134 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -99.26 160.5 27.42 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.627 0.727 . . . . 72.22 110.925 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -19.53 36.0 Favored 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.697 2.264 . . . . 73.03 112.376 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -68.63 -19.65 64.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 60.11 110.924 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.21 6.01 36.98 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.716 -0.754 . . . . 70.34 112.512 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 t -116.1 168.97 9.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.866 0.365 . . . . 62.41 110.851 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 23.0 pt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.068 -0.515 . . . . 74.44 111.087 -179.996 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.4 mtpt . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.817 0.341 . . . . 75.12 110.886 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -83.13 125.26 40.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 72.55 111.15 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -97.95 160.51 28.27 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.67 0.748 . . . . 74.31 110.919 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 -18.99 37.15 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.705 2.27 . . . . 70.53 112.354 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -70.17 -19.68 63.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 63.53 110.873 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.1 6.1 37.18 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.726 -0.749 . . . . 74.55 112.476 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 t -117.79 173.73 6.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.892 0.377 . . . . 45.0 110.813 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 20.4 pt . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 71.03 111.119 179.977 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.863 0.363 . . . . 71.23 110.901 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.5 t -76.96 124.53 35.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 73.15 111.159 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -98.16 160.6 27.91 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.673 0.749 . . . . 72.52 110.879 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -19.01 36.7 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.716 2.277 . . . . 54.55 112.259 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -69.78 -19.64 63.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.427 . . . . 72.13 110.901 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.09 6.13 37.17 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.744 -0.741 . . . . 71.4 112.52 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 t -117.14 171.57 7.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.9 0.381 . . . . 64.34 110.818 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 21.9 pt . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 72.2 111.114 179.978 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.7 tttp . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.789 0.328 . . . . 60.35 110.964 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.8 t -88.44 129.18 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 65.44 111.179 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -98.97 160.6 27.32 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.707 0.765 . . . . 74.24 110.906 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -19.03 36.62 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.657 2.238 . . . . 64.01 112.373 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -69.32 -19.61 63.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 75.32 110.827 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.05 6.1 37.31 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.73 -0.748 . . . . 64.24 112.479 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.2 t -117.15 171.08 8.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.854 0.359 . . . . 53.42 110.853 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.8 mp . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 53.5 111.113 179.925 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.836 0.351 . . . . 75.25 110.909 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p -88.3 128.76 40.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.439 . . . . 53.3 111.087 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -99.1 160.65 27.13 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.623 0.725 . . . . 74.24 110.927 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 -19.08 36.22 Favored 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.651 2.234 . . . . 71.32 112.337 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -69.21 -19.69 63.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 40.32 110.87 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.15 6.08 37.06 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.77 -0.729 . . . . 72.45 112.48 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.2 t -117.13 171.11 8.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.853 0.358 . . . . 74.13 110.878 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 17.0 pt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 73.34 111.096 179.938 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.809 0.338 . . . . 75.43 110.924 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.3 t -88.02 134.12 28.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 71.43 111.087 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -97.98 160.61 27.99 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.693 0.759 . . . . 73.2 110.947 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.74 -18.71 36.96 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.706 2.271 . . . . 73.34 112.37 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -70.13 -19.65 63.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 75.11 110.925 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.13 6.08 37.12 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.697 -0.763 . . . . 75.31 112.504 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.7 t -116.06 169.11 9.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.811 0.338 . . . . 55.3 110.845 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 25.7 mm . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 65.32 111.149 179.909 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.5 ttpp . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.814 0.34 . . . . 72.45 110.92 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.4 t -88.08 134.94 26.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 61.33 111.147 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -99.53 160.6 27.0 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.653 0.74 . . . . 71.42 110.944 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -20.06 35.3 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.715 2.276 . . . . 62.3 112.297 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -68.02 -19.73 64.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 32.4 110.887 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.14 6.16 37.01 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.742 -0.742 . . . . 71.41 112.455 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.2 t -115.87 168.7 9.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.868 0.366 . . . . 73.54 110.874 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 62.4 mt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 74.4 111.064 179.978 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.6 mtpt . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.849 0.357 . . . . 74.34 110.924 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.5 t -90.58 131.42 37.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 74.05 111.178 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -99.76 160.65 26.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.738 0.78 . . . . 75.43 110.928 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 -19.83 35.24 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.67 2.247 . . . . 75.04 112.37 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -68.11 -19.67 64.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 73.41 110.86 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.08 6.16 37.16 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.805 -0.712 . . . . 60.12 112.458 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 t -116.0 168.67 9.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.87 0.367 . . . . 73.0 110.817 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 58.4 mt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.089 -0.505 . . . . 74.41 111.111 179.927 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.873 0.368 . . . . 75.22 110.911 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.8 p -87.77 131.06 36.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.207 -0.451 . . . . 74.41 111.143 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -99.65 160.56 27.06 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.661 0.744 . . . . 63.31 110.908 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.85 -19.45 35.69 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.629 2.219 . . . . 70.43 112.299 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -68.73 -19.62 64.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.246 -0.434 . . . . 65.31 110.845 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.13 6.07 37.13 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.665 -0.779 . . . . 50.31 112.514 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 t -116.4 169.93 8.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.361 . . . . 71.23 110.935 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 16.3 pt . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.17 -0.468 . . . . 71.44 111.176 179.962 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 11.1 tptm . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.764 0.316 . . . . 73.22 110.916 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.2 t -90.89 129.26 41.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 63.12 111.147 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -98.58 160.5 27.85 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.762 0.791 . . . . 74.05 110.878 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -19.59 35.95 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.748 2.299 . . . . 62.32 112.354 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -69.04 -19.59 64.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.456 . . . . 71.33 110.798 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.11 6.0 37.26 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.701 -0.761 . . . . 71.4 112.457 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.6 t -115.57 169.03 9.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.9 0.381 . . . . 61.11 110.869 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.0 mp . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 62.52 111.164 179.935 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.857 0.36 . . . . 63.11 110.884 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.4 p -87.51 132.45 32.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.445 . . . . 64.53 111.15 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -99.04 160.53 27.47 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.668 0.747 . . . . 73.33 110.891 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -19.46 36.24 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.657 2.238 . . . . 74.32 112.344 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -68.89 -19.53 64.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.254 -0.43 . . . . 72.41 110.834 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.04 6.11 37.34 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.725 -0.75 . . . . 41.13 112.522 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 t -115.81 168.65 9.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.88 0.372 . . . . 73.13 110.832 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 41.8 mm . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 74.04 111.115 179.976 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.813 0.339 . . . . 62.13 110.915 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.6 p -97.53 134.3 36.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 72.42 111.099 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -99.98 160.6 26.77 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.705 0.764 . . . . 75.32 110.91 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -19.88 35.5 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.684 2.256 . . . . 73.11 112.335 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -68.05 -19.6 64.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 61.4 110.842 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.19 5.98 37.07 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.696 -0.764 . . . . 60.34 112.475 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.0 t -115.07 167.09 11.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.852 0.358 . . . . 64.43 110.876 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 62.8 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.484 . . . . 74.34 111.091 179.905 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.827 0.346 . . . . 73.41 110.889 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.4 t -95.03 131.42 41.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.445 . . . . 63.21 111.159 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -99.48 160.63 26.95 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.597 0.713 . . . . 74.21 110.975 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.85 -20.08 34.88 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.733 2.289 . . . . 61.23 112.312 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -68.25 -19.56 64.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 71.24 110.843 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.06 6.17 37.21 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.781 -0.724 . . . . 74.43 112.49 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 t -114.65 167.01 11.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.858 0.361 . . . . 64.24 110.871 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.5 mp . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.46 . . . . 71.15 111.141 179.905 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.824 0.345 . . . . 75.51 110.943 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.407 HG22 HD12 ' A' ' 12' ' ' ILE . 22.0 t -90.42 132.11 35.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 44.0 111.1 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -98.03 160.54 28.13 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.697 0.761 . . . . 61.3 110.939 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 -20.89 34.19 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.735 2.29 . . . . 74.13 112.364 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -68.19 -19.55 64.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 71.11 110.881 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.12 6.07 37.16 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.719 -0.753 . . . . 43.12 112.438 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.6 t -114.19 168.08 10.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.91 0.386 . . . . 71.02 110.867 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.407 HD12 HG22 ' A' ' 6' ' ' VAL . 25.3 mm . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.119 -0.492 . . . . 64.5 111.102 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.5 ttmm . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.867 0.365 . . . . 70.34 110.881 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.9 p -102.35 131.31 50.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 63.44 111.163 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -98.35 160.5 28.01 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.632 0.729 . . . . 74.42 110.962 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -20.19 35.25 Favored 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.696 2.264 . . . . 71.11 112.417 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -68.6 -19.42 64.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 74.13 110.901 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.07 6.11 37.26 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.743 -0.741 . . . . 73.32 112.489 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.5 t -114.62 167.32 10.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.842 0.353 . . . . 71.32 110.817 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.1 pt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 74.43 111.178 179.915 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.9 ttmt . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.809 0.338 . . . . 53.53 110.89 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.7 p -89.12 129.98 39.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 64.22 111.111 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -99.72 160.56 27.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.684 0.754 . . . . 71.34 110.95 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -19.89 35.66 Favored 'Trans proline' 0 C--N 1.34 0.115 0 C-N-CA 122.69 2.26 . . . . 74.33 112.335 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.34 -19.45 64.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 60.01 110.842 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.09 6.14 37.16 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 73.31 112.45 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.6 t -114.87 166.68 11.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.824 0.345 . . . . 50.42 110.859 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.6 mp . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 70.05 111.134 179.959 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 52.0 mttt . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.779 0.323 . . . . 71.32 110.913 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -94.57 131.34 41.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 72.21 111.146 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -99.69 160.66 26.76 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.707 0.765 . . . . 71.33 110.934 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.84 -19.29 35.93 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.658 2.239 . . . . 74.24 112.367 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -68.56 -19.47 64.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 63.21 110.939 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.06 6.12 37.26 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.779 -0.724 . . . . 65.11 112.523 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.2 t -114.28 164.62 13.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.915 0.388 . . . . 74.22 110.777 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.2 mp . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 74.54 111.097 179.958 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.4 mttp . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.834 0.35 . . . . 73.33 110.919 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.4 t -92.96 132.4 37.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 74.22 111.1 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -99.74 160.57 26.98 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.618 0.723 . . . . 75.04 110.965 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -19.98 35.53 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.653 2.235 . . . . 73.52 112.292 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 -68.09 -19.53 64.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 63.31 110.852 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.16 6.12 36.98 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 64.03 112.453 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 t -113.78 164.76 13.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.798 0.333 . . . . 73.33 110.85 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 55.6 mt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 75.13 111.112 179.937 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 31.3 tttt . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.823 0.345 . . . . 73.22 110.944 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -105.22 132.79 51.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 75.41 111.106 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -99.98 160.6 26.77 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.656 0.741 . . . . 74.03 110.953 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 -19.77 35.41 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.697 2.265 . . . . 74.44 112.322 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -68.04 -19.47 64.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 74.34 110.939 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.06 6.09 37.29 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.778 -0.725 . . . . 71.52 112.504 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 t -114.39 165.32 12.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.898 0.38 . . . . 73.45 110.815 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 29.0 pt . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.123 -0.489 . . . . 62.13 111.05 179.987 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.834 0.35 . . . . 74.23 110.905 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.9 p -97.32 136.74 27.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.295 -0.411 . . . . 75.44 111.147 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -100.0 160.59 26.8 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.717 0.77 . . . . 75.11 110.922 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -19.77 35.81 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.642 2.228 . . . . 71.12 112.411 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -68.06 -19.5 64.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 74.43 110.877 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.12 6.0 37.23 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.747 -0.739 . . . . 71.3 112.531 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.9 t -113.8 164.28 13.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.876 0.37 . . . . 30.41 110.836 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 31.6 mt . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 75.13 111.135 179.969 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.838 0.351 . . . . 64.33 110.829 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 11.4 m -129.21 162.13 28.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 63.35 110.934 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.5 tppt? -142.16 123.48 14.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 73.02 110.889 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -59.19 133.15 55.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 55.11 110.86 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -88.68 127.21 35.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.457 . . . . 71.51 110.954 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.5 p -93.73 130.85 42.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.26 -0.427 . . . . 71.04 111.134 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -99.26 160.5 27.42 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.627 0.727 . . . . 72.22 110.925 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -19.53 36.0 Favored 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.697 2.264 . . . . 73.03 112.376 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -68.63 -19.65 64.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 60.11 110.924 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.21 6.01 36.98 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.716 -0.754 . . . . 70.34 112.512 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 t -116.1 168.97 9.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.866 0.365 . . . . 62.41 110.851 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 23.0 pt -115.54 148.3 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.068 -0.515 . . . . 74.44 111.087 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.0 t -99.12 133.87 42.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.481 . . . . 62.54 110.839 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -99.17 61.06 1.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 71.52 110.866 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -148.13 116.88 6.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 74.0 110.904 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.1 t -113.13 144.61 42.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 63.04 110.902 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -87.18 133.68 33.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 73.32 110.857 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 13.7 p90 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 71.43 110.859 -179.802 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.6 t70 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.846 0.355 . . . . 63.24 110.848 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 5.8 t -129.19 150.14 50.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 73.03 110.887 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -113.68 114.9 27.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 72.5 110.833 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -58.94 128.63 38.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 75.15 110.829 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.4 mtpt -91.22 122.19 33.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 75.12 110.886 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -83.13 125.26 40.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 72.55 111.15 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -97.95 160.51 28.27 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.67 0.748 . . . . 74.31 110.919 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 -18.99 37.15 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.705 2.27 . . . . 70.53 112.354 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -70.17 -19.68 63.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 63.53 110.873 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.1 6.1 37.18 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.726 -0.749 . . . . 74.55 112.476 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 t -117.79 173.73 6.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.892 0.377 . . . . 45.0 110.813 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 20.4 pt -108.87 154.84 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 71.03 111.119 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 t -63.04 136.66 57.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 64.34 110.819 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -106.72 51.91 0.73 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.08 -0.509 . . . . 71.35 110.855 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -164.88 142.47 6.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 70.15 110.891 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 m -147.02 139.2 24.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.106 -0.497 . . . . 74.12 110.86 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -130.78 148.58 52.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 75.31 110.929 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 72.34 110.889 -179.89 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.838 0.351 . . . . 75.33 110.856 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 45.2 t -134.15 140.11 46.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 73.22 110.858 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -81.45 120.09 24.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.125 -0.489 . . . . 45.41 110.89 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 35.0 ptt85 -54.01 137.62 39.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 72.33 110.888 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -99.13 114.22 26.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 71.23 110.901 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.5 t -76.96 124.53 35.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 73.15 111.159 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -98.16 160.6 27.91 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.673 0.749 . . . . 72.52 110.879 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -19.01 36.7 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.716 2.277 . . . . 54.55 112.259 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -69.78 -19.64 63.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.427 . . . . 72.13 110.901 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.09 6.13 37.17 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.744 -0.741 . . . . 71.4 112.52 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 t -117.14 171.57 7.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.9 0.381 . . . . 64.34 110.818 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 21.9 pt -110.92 140.87 28.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 72.2 111.114 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.3 t -61.71 176.93 0.46 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 53.31 110.851 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -134.08 -43.84 0.79 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.501 . . . . 74.5 110.886 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -89.0 147.34 24.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 71.02 110.98 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 82.9 m -121.29 166.62 13.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 75.23 110.879 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -105.27 136.98 43.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 62.24 110.886 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 62.13 110.952 -179.903 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.798 0.332 . . . . 75.42 110.86 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 30.9 p -116.57 157.45 25.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 72.12 110.922 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.43 148.54 52.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 71.41 110.85 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 53.3 mtt85 -60.3 157.0 14.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 53.11 110.844 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.7 tttp -129.97 130.65 45.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 60.35 110.964 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.8 t -88.44 129.18 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 65.44 111.179 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -98.97 160.6 27.32 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.707 0.765 . . . . 74.24 110.906 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -19.03 36.62 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.657 2.238 . . . . 64.01 112.373 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -69.32 -19.61 63.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 75.32 110.827 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.05 6.1 37.31 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.73 -0.748 . . . . 64.24 112.479 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.2 t -117.15 171.08 8.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.854 0.359 . . . . 53.42 110.853 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.8 mp -115.06 140.6 35.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 53.5 111.113 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.0 t -79.29 129.95 34.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 75.13 110.864 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -116.43 74.05 0.88 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.123 -0.489 . . . . 52.24 110.904 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -150.27 131.95 14.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.15 -0.477 . . . . 75.14 110.953 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.9 t -135.77 149.61 49.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 61.54 110.903 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -88.35 147.18 24.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 64.1 110.865 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 17.6 p90 . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 75.34 110.91 -179.879 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 . . . . . 0 C--O 1.232 0.171 0 CA-C-O 120.827 0.346 . . . . 75.31 110.888 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 43.7 t -137.07 143.57 42.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 75.22 110.906 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -72.75 140.35 47.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 74.2 110.978 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.56 130.17 55.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.314 -0.403 . . . . 72.42 110.871 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.22 122.17 23.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.261 -0.427 . . . . 75.25 110.909 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p -88.3 128.76 40.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.439 . . . . 53.3 111.087 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -99.1 160.65 27.13 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.623 0.725 . . . . 74.24 110.927 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 -19.08 36.22 Favored 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.651 2.234 . . . . 71.32 112.337 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -69.21 -19.69 63.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 40.32 110.87 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.15 6.08 37.06 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.77 -0.729 . . . . 72.45 112.48 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.2 t -117.13 171.11 8.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.853 0.358 . . . . 74.13 110.878 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 17.0 pt -112.29 154.17 13.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 73.34 111.096 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 t -56.89 178.58 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 72.44 110.867 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -111.69 -34.68 5.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 72.34 110.864 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -127.6 142.15 51.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.195 -0.457 . . . . 62.24 110.906 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.0 p -127.32 152.79 47.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 64.31 110.876 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -141.69 152.59 44.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 61.54 110.932 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 74.9 t80 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.178 -0.464 . . . . 74.24 110.974 -179.86 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.0 t70 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.886 0.374 . . . . 64.41 110.831 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 10.6 t -115.05 138.2 51.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 71.44 110.893 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -63.88 131.55 48.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 64.3 110.879 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.29 170.19 10.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 73.44 110.858 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -135.97 142.76 44.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.192 -0.458 . . . . 75.43 110.924 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.3 t -88.02 134.12 28.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 71.43 111.087 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -97.98 160.61 27.99 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.693 0.759 . . . . 73.2 110.947 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.74 -18.71 36.96 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.706 2.271 . . . . 73.34 112.37 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -70.13 -19.65 63.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 75.11 110.925 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.13 6.08 37.12 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.697 -0.763 . . . . 75.31 112.504 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.7 t -116.06 169.11 9.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.811 0.338 . . . . 55.3 110.845 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 25.7 mm -102.04 144.38 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 65.32 111.149 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.1 p -58.42 147.02 32.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.507 . . . . 61.25 110.905 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.44 41.93 3.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 64.43 110.912 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -143.51 153.4 42.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.435 . . . . 72.45 110.96 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.6 m -130.41 155.57 46.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 63.25 110.818 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -107.02 146.27 31.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.505 . . . . 64.51 110.885 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 6.7 t80 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 75.3 110.919 -179.88 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.846 0.355 . . . . 72.5 110.875 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.3 m -122.62 149.96 43.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 72.34 110.851 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.8 mttm -146.01 149.77 34.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 72.32 110.96 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -59.35 154.57 16.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 74.02 110.931 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.5 ttpp -138.46 131.84 30.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 72.45 110.92 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.4 t -88.08 134.94 26.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 61.33 111.147 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -99.53 160.6 27.0 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.653 0.74 . . . . 71.42 110.944 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -20.06 35.3 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.715 2.276 . . . . 62.3 112.297 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -68.02 -19.73 64.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 32.4 110.887 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.14 6.16 37.01 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.742 -0.742 . . . . 71.41 112.455 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.2 t -115.87 168.7 9.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.868 0.366 . . . . 73.54 110.874 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 62.4 mt -109.41 142.49 21.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 74.4 111.064 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.0 p -70.05 160.81 31.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 62.12 110.869 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -109.16 -43.76 4.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 71.11 110.903 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -105.19 166.91 10.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.087 -0.506 . . . . 74.13 110.951 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.1 p -114.77 154.48 28.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.115 -0.493 . . . . 61.42 110.904 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -139.75 143.06 36.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 72.52 110.909 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 70.7 t80 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.154 -0.475 . . . . 72.13 110.916 -179.84 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.863 0.363 . . . . 72.42 110.866 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 47.8 t -125.51 146.07 49.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 74.24 110.836 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 48.0 tttp -69.22 117.2 10.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 74.22 110.943 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -91.69 170.98 9.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 74.55 110.81 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.6 mtpt -123.94 135.15 53.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 74.34 110.924 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.5 t -90.58 131.42 37.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 74.05 111.178 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -99.76 160.65 26.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.738 0.78 . . . . 75.43 110.928 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 -19.83 35.24 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.67 2.247 . . . . 75.04 112.37 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -68.11 -19.67 64.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 73.41 110.86 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.08 6.16 37.16 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.805 -0.712 . . . . 60.12 112.458 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 t -116.0 168.67 9.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.87 0.367 . . . . 73.0 110.817 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 58.4 mt -115.95 143.53 25.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.089 -0.505 . . . . 74.41 111.111 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.5 t -58.4 149.01 25.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 73.21 110.901 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -92.38 -43.27 9.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 63.52 110.884 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -109.36 154.11 23.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 73.14 110.956 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.0 p -122.6 143.3 49.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 44.13 110.882 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -132.09 129.47 39.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 53.43 110.869 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 75.6 t80 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.104 -0.498 . . . . 73.34 110.889 -179.812 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.903 0.383 . . . . 65.43 110.877 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 2.7 m -118.39 167.91 11.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 74.13 110.847 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.84 120.71 11.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 73.33 110.884 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.5 ptp85 -52.51 103.44 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 72.23 110.85 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt -68.85 111.18 4.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 75.22 110.911 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.8 p -87.77 131.06 36.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.207 -0.451 . . . . 74.41 111.143 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -99.65 160.56 27.06 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.661 0.744 . . . . 63.31 110.908 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.85 -19.45 35.69 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.629 2.219 . . . . 70.43 112.299 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -68.73 -19.62 64.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.246 -0.434 . . . . 65.31 110.845 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.13 6.07 37.13 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.665 -0.779 . . . . 50.31 112.514 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 t -116.4 169.93 8.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.361 . . . . 71.23 110.935 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 16.3 pt -112.79 149.83 15.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.17 -0.468 . . . . 71.44 111.176 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.5 m -74.89 -177.0 3.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.295 -0.411 . . . . 70.1 110.841 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -118.48 -65.72 1.15 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.042 -0.526 . . . . 74.3 110.884 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -75.73 140.08 42.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.229 -0.441 . . . . 72.03 110.932 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.1 p -120.75 139.59 52.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 61.0 110.839 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -86.37 146.13 26.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.481 . . . . 71.32 110.899 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 33.2 p90 . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 64.52 110.967 -179.951 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 24.1 t0 . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.825 0.345 . . . . 64.42 110.811 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 63.4 m -133.88 144.33 48.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.448 . . . . 63.43 110.894 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.08 123.54 50.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 73.14 110.901 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 85.2 mtm-85 -88.23 98.93 11.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 71.55 110.883 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 11.1 tptm -95.28 128.97 42.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.45 . . . . 73.22 110.916 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.2 t -90.89 129.26 41.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 63.12 111.147 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -98.58 160.5 27.85 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.762 0.791 . . . . 74.05 110.878 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -19.59 35.95 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.748 2.299 . . . . 62.32 112.354 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -69.04 -19.59 64.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.456 . . . . 71.33 110.798 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.11 6.0 37.26 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.701 -0.761 . . . . 71.4 112.457 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.6 t -115.57 169.03 9.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.9 0.381 . . . . 61.11 110.869 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.0 mp -113.24 149.84 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 62.52 111.164 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.7 t -93.02 143.32 26.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 71.1 110.882 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -113.95 64.52 0.66 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.177 -0.465 . . . . 63.14 110.848 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -100.31 134.83 42.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 73.31 110.944 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 98.4 m -131.34 144.22 51.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.086 -0.506 . . . . 52.55 110.891 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -106.29 152.61 23.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 75.24 110.854 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 52.5 t80 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 74.33 110.942 -179.869 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.81 0.338 . . . . 71.32 110.89 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.0 p -138.93 149.54 44.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 63.52 110.882 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.8 mmtm -108.95 139.37 43.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.225 -0.443 . . . . 61.24 110.864 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -65.2 140.2 58.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 74.44 110.869 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? -103.87 124.89 49.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 63.11 110.884 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.4 p -87.51 132.45 32.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.445 . . . . 64.53 111.15 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -99.04 160.53 27.47 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.668 0.747 . . . . 73.33 110.891 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -19.46 36.24 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.657 2.238 . . . . 74.32 112.344 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -68.89 -19.53 64.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.254 -0.43 . . . . 72.41 110.834 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.04 6.11 37.34 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.725 -0.75 . . . . 41.13 112.522 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 t -115.81 168.65 9.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.88 0.372 . . . . 73.13 110.832 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 41.8 mm -111.26 145.85 16.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 74.04 111.115 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.7 t -81.69 146.69 29.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 64.32 110.904 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -114.89 41.45 2.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 73.24 110.862 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -122.42 147.56 46.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 71.21 110.958 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.8 m -141.47 147.86 38.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 70.21 110.865 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -106.69 121.11 43.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 63.23 110.866 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 41.3 p90 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 70.15 110.89 -179.843 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.883 0.373 . . . . 74.31 110.933 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 35.3 m -126.85 156.04 41.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 74.43 110.898 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 43.4 mmtt -112.09 137.41 50.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 72.24 110.924 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.5 ppt_? -74.76 167.6 21.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.42 . . . . 75.54 110.874 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -146.24 153.19 40.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 62.13 110.915 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.6 p -97.53 134.3 36.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 72.42 111.099 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -99.98 160.6 26.77 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.705 0.764 . . . . 75.32 110.91 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -19.88 35.5 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.684 2.256 . . . . 73.11 112.335 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -68.05 -19.6 64.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 61.4 110.842 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.19 5.98 37.07 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.696 -0.764 . . . . 60.34 112.475 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.0 t -115.07 167.09 11.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.852 0.358 . . . . 64.43 110.876 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 62.8 mt -114.57 144.8 21.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.484 . . . . 74.34 111.091 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.3 t -82.21 140.96 33.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 22.22 110.871 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -113.64 -31.48 6.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 53.3 110.902 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -84.98 159.64 20.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.212 -0.449 . . . . 73.51 110.917 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 36.5 t -124.94 131.5 53.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 73.15 110.896 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -121.33 152.54 38.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 72.53 110.904 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 50.3 p90 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.21 -0.45 . . . . 74.43 110.891 -179.966 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.84 0.352 . . . . 74.23 110.819 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.8 m -122.49 169.91 10.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.09 -0.505 . . . . 74.11 110.821 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.1 tttp -70.24 135.38 48.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.497 . . . . 61.53 110.938 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -107.93 144.02 35.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 55.13 110.875 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -118.09 126.39 52.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 73.41 110.889 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.4 t -95.03 131.42 41.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.445 . . . . 63.21 111.159 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -99.48 160.63 26.95 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.597 0.713 . . . . 74.21 110.975 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.85 -20.08 34.88 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.733 2.289 . . . . 61.23 112.312 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -68.25 -19.56 64.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 71.24 110.843 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.06 6.17 37.21 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.781 -0.724 . . . . 74.43 112.49 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 t -114.65 167.01 11.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.858 0.361 . . . . 64.24 110.871 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.28 145.47 23.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.46 . . . . 71.15 111.141 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.6 t -104.27 134.3 47.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 74.41 110.814 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -109.29 88.54 2.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.061 -0.518 . . . . 73.02 110.845 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -141.78 127.18 18.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 71.11 110.908 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.9 t -116.43 140.32 49.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 74.02 110.824 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -73.85 151.19 40.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 71.32 110.822 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 44.5 p90 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.144 -0.48 . . . . 74.41 110.933 -179.905 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.809 0.337 . . . . 74.32 110.91 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 16.6 t -132.37 144.26 50.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 62.34 110.836 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -79.19 148.56 32.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 74.22 110.927 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.12 137.26 48.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 71.22 110.912 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -125.8 133.37 52.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 75.51 110.943 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.407 HG22 HD12 ' A' ' 12' ' ' ILE . 22.0 t -90.42 132.11 35.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 44.0 111.1 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -98.03 160.54 28.13 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.697 0.761 . . . . 61.3 110.939 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 -20.89 34.19 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.735 2.29 . . . . 74.13 112.364 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -68.19 -19.55 64.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 71.11 110.881 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.12 6.07 37.16 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.719 -0.753 . . . . 43.12 112.438 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.6 t -114.19 168.08 10.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.91 0.386 . . . . 71.02 110.867 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.407 HD12 HG22 ' A' ' 6' ' ' VAL . 25.3 mm -107.82 146.26 14.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.119 -0.492 . . . . 64.5 111.102 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.5 m -67.34 121.08 14.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 70.22 110.832 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -91.61 -41.62 10.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.116 -0.493 . . . . 64.24 110.841 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -71.21 166.42 21.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 73.32 110.951 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 92.3 m -124.4 134.34 53.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 75.43 110.945 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -96.27 140.07 31.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 73.42 110.871 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.113 -0.494 . . . . 70.32 110.905 -179.86 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 34.3 t70 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.883 0.373 . . . . 63.13 110.92 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 44.0 t -150.43 134.75 17.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.437 . . . . 73.23 110.885 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -72.81 144.98 47.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 74.31 110.95 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 88.0 mtt180 -57.3 115.73 2.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 75.31 110.839 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.5 ttmm -67.22 133.03 48.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 70.34 110.881 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.9 p -102.35 131.31 50.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 63.44 111.163 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -98.35 160.5 28.01 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.632 0.729 . . . . 74.42 110.962 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -20.19 35.25 Favored 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.696 2.264 . . . . 71.11 112.417 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -68.6 -19.42 64.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 74.13 110.901 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.07 6.11 37.26 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.743 -0.741 . . . . 73.32 112.489 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.5 t -114.62 167.32 10.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.842 0.353 . . . . 71.32 110.817 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.1 pt -111.87 153.13 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 74.43 111.178 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.8 t -70.61 161.81 30.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 61.34 110.849 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -81.07 -53.12 6.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 74.43 110.827 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -136.2 174.63 10.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 72.23 110.874 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 13.9 t -121.79 125.89 47.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 74.43 110.849 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -68.15 145.06 54.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.096 -0.502 . . . . 64.15 110.919 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 13.1 t80 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.092 -0.504 . . . . 72.34 110.935 -179.851 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.857 0.36 . . . . 63.11 110.86 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 12.1 t -130.35 152.46 49.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 75.41 110.862 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -80.53 111.57 17.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 64.4 110.894 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.95 147.49 7.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 72.23 110.88 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.9 ttmt -105.26 115.33 30.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 53.53 110.89 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.7 p -89.12 129.98 39.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 64.22 111.111 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -99.72 160.56 27.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.684 0.754 . . . . 71.34 110.95 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -19.89 35.66 Favored 'Trans proline' 0 C--N 1.34 0.115 0 C-N-CA 122.69 2.26 . . . . 74.33 112.335 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.34 -19.45 64.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 60.01 110.842 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.09 6.14 37.16 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 73.31 112.45 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.6 t -114.87 166.68 11.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.824 0.345 . . . . 50.42 110.859 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.6 mp -118.45 138.26 49.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 70.05 111.134 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.3 t -94.78 128.12 41.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 32.21 110.873 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -93.66 60.3 2.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.486 . . . . 70.0 110.839 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -137.44 152.76 49.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 75.31 110.921 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 16.3 t -135.21 129.99 34.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 71.52 110.895 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -61.82 137.19 58.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 63.33 110.796 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 36.9 p90 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 74.43 110.996 -179.92 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 . . . . . 0 N--CA 1.457 -0.093 0 CA-C-O 120.86 0.362 . . . . 64.33 110.905 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 34.9 m -122.96 145.29 48.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 71.32 110.895 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -81.18 126.36 31.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.465 . . . . 64.44 110.875 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -88.12 131.85 34.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.291 -0.413 . . . . 65.22 110.889 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -138.82 137.16 36.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 71.32 110.913 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -94.57 131.34 41.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 72.21 111.146 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -99.69 160.66 26.76 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.707 0.765 . . . . 71.33 110.934 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.84 -19.29 35.93 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.658 2.239 . . . . 74.24 112.367 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -68.56 -19.47 64.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 63.21 110.939 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.06 6.12 37.26 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.779 -0.724 . . . . 65.11 112.523 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.2 t -114.28 164.62 13.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.915 0.388 . . . . 74.22 110.777 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.2 mp -119.25 143.23 31.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 74.54 111.097 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.4 m -69.75 116.74 10.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 73.35 110.807 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -83.61 -64.63 1.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.081 -0.509 . . . . 62.52 110.827 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -89.6 156.86 18.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 72.41 110.912 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.7 p -118.3 144.4 45.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 55.42 110.94 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -77.76 143.49 37.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 74.31 110.961 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 33.4 p90 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 71.42 110.886 -179.799 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.861 0.362 . . . . 61.04 110.826 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 7.5 p -119.91 159.48 24.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 61.42 110.848 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -63.17 122.7 16.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 75.41 110.875 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -69.56 110.53 4.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 62.33 110.873 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.4 mttp -76.95 116.73 17.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 73.33 110.919 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.4 t -92.96 132.4 37.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 74.22 111.1 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -99.74 160.57 26.98 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.618 0.723 . . . . 75.04 110.965 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -19.98 35.53 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.653 2.235 . . . . 73.52 112.292 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 -68.09 -19.53 64.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 63.31 110.852 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.16 6.12 36.98 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 64.03 112.453 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 t -113.78 164.76 13.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.798 0.333 . . . . 73.33 110.85 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 55.6 mt -117.64 144.07 26.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 75.13 111.112 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 m -103.0 129.46 49.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.482 . . . . 75.13 110.863 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -110.8 39.03 2.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.078 -0.51 . . . . 72.21 110.832 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -120.86 103.99 9.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.45 . . . . 55.1 110.916 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.1 p -127.22 130.78 50.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 73.43 110.867 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -63.04 125.15 23.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.104 -0.498 . . . . 62.14 110.889 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.6 p90 . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 116.179 -0.464 . . . . 62.01 110.969 -179.897 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.85 0.357 . . . . 61.35 110.822 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 24.5 m -140.79 144.54 35.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 62.13 110.857 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.5 ptmm? -114.52 127.85 56.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 63.22 110.877 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 86.2 mtm180 -74.76 119.51 19.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 73.34 110.902 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 31.3 tttt -69.12 142.28 54.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.44 . . . . 73.22 110.944 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -105.22 132.79 51.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 75.41 111.106 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -99.98 160.6 26.77 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.656 0.741 . . . . 74.03 110.953 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 -19.77 35.41 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.697 2.265 . . . . 74.44 112.322 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -68.04 -19.47 64.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 74.34 110.939 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.06 6.09 37.29 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.778 -0.725 . . . . 71.52 112.504 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 t -114.39 165.32 12.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.898 0.38 . . . . 73.45 110.815 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 29.0 pt -116.24 156.14 17.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.123 -0.489 . . . . 62.13 111.05 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.3 t -121.38 167.36 12.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.139 -0.482 . . . . 74.23 110.933 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -112.34 91.3 3.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.179 -0.464 . . . . 73.53 110.798 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -130.89 154.14 48.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 72.44 110.882 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 61.7 m -124.75 129.58 50.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.113 -0.494 . . . . 42.12 110.886 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -102.16 146.1 28.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 75.01 110.9 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.1 p90 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.234 -0.439 . . . . 75.25 110.92 -179.9 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.3 t70 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.871 0.367 . . . . 75.11 110.885 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 30.9 t -135.31 143.97 46.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 71.51 110.875 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -91.8 115.85 28.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 72.22 110.833 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 78.5 mtm-85 -59.65 131.36 50.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 74.14 110.839 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -105.9 132.22 52.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 74.23 110.905 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.9 p -97.32 136.74 27.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.295 -0.411 . . . . 75.44 111.147 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -100.0 160.59 26.8 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.717 0.77 . . . . 75.11 110.922 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -19.77 35.81 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.642 2.228 . . . . 71.12 112.411 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -68.06 -19.5 64.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 74.43 110.877 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.12 6.0 37.23 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.747 -0.739 . . . . 71.3 112.531 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.9 t -113.8 164.28 13.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.876 0.37 . . . . 30.41 110.836 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 31.6 mt -112.25 137.95 43.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 75.13 111.135 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.9 t -57.04 149.11 19.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 61.32 110.832 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -106.38 -38.22 6.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.511 . . . . 63.4 110.876 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -119.23 138.48 52.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 70.44 110.935 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 6.1 p -133.55 159.72 39.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.112 -0.495 . . . . 64.14 110.932 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -94.33 141.57 28.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 62.22 110.914 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 35.9 t80 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.143 -0.48 . . . . 72.52 110.933 -179.861 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.792 0.33 . . . . 71.510000000000005 110.954 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.5 p -93.73 130.85 42.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.26 -0.427 . . . . 71.040000000000006 111.134 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -99.26 160.5 27.42 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.627 0.727 . . . . 72.219999999999999 110.925 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -19.53 36.0 Favored 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.697 2.264 . . . . 73.030000000000001 112.376 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -68.63 -19.65 64.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 60.109999999999999 110.924 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.21 6.01 36.98 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.716 -0.754 . . . . 70.340000000000003 112.512 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 t -116.1 168.97 9.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.866 0.365 . . . . 62.409999999999997 110.851 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 23.0 pt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.068 -0.515 . . . . 74.439999999999998 111.087 -179.996 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.4 mtpt . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.817 0.341 . . . . 75.120000000000005 110.886 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -83.13 125.26 40.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 72.549999999999997 111.15 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -97.95 160.51 28.27 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.67 0.748 . . . . 74.310000000000002 110.919 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 -18.99 37.15 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.705 2.27 . . . . 70.530000000000001 112.354 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -70.17 -19.68 63.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 63.530000000000001 110.873 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.1 6.1 37.18 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.726 -0.749 . . . . 74.549999999999997 112.476 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 t -117.79 173.73 6.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.892 0.377 . . . . 45.0 110.813 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 20.4 pt . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 71.030000000000001 111.119 179.977 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.863 0.363 . . . . 71.230000000000004 110.901 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.5 t -76.96 124.53 35.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 73.150000000000006 111.159 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -98.16 160.6 27.91 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.673 0.749 . . . . 72.519999999999996 110.879 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -19.01 36.7 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.716 2.277 . . . . 54.549999999999997 112.259 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -69.78 -19.64 63.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.427 . . . . 72.129999999999995 110.901 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.09 6.13 37.17 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.744 -0.741 . . . . 71.400000000000006 112.52 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 t -117.14 171.57 7.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.9 0.381 . . . . 64.340000000000003 110.818 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 21.9 pt . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 72.200000000000003 111.114 179.978 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.7 tttp . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.789 0.328 . . . . 60.350000000000001 110.964 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.8 t -88.44 129.18 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 65.439999999999998 111.179 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -98.97 160.6 27.32 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.707 0.765 . . . . 74.239999999999995 110.906 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -19.03 36.62 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.657 2.238 . . . . 64.010000000000005 112.373 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -69.32 -19.61 63.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 75.319999999999993 110.827 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.05 6.1 37.31 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.73 -0.748 . . . . 64.239999999999995 112.479 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.2 t -117.15 171.08 8.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.854 0.359 . . . . 53.420000000000002 110.853 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.8 mp . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 53.5 111.113 179.925 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.836 0.351 . . . . 75.25 110.909 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p -88.3 128.76 40.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.439 . . . . 53.299999999999997 111.087 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -99.1 160.65 27.13 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.623 0.725 . . . . 74.239999999999995 110.927 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 -19.08 36.22 Favored 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.651 2.234 . . . . 71.319999999999993 112.337 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -69.21 -19.69 63.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 40.32 110.87 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.15 6.08 37.06 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.77 -0.729 . . . . 72.450000000000003 112.48 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.2 t -117.13 171.11 8.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.853 0.358 . . . . 74.129999999999995 110.878 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 17.0 pt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 73.340000000000003 111.096 179.938 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.809 0.338 . . . . 75.430000000000007 110.924 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.3 t -88.02 134.12 28.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 71.430000000000007 111.087 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -97.98 160.61 27.99 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.693 0.759 . . . . 73.200000000000003 110.947 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.74 -18.71 36.96 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.706 2.271 . . . . 73.340000000000003 112.37 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -70.13 -19.65 63.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 75.109999999999999 110.925 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.13 6.08 37.12 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.697 -0.763 . . . . 75.310000000000002 112.504 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.7 t -116.06 169.11 9.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.811 0.338 . . . . 55.299999999999997 110.845 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 25.7 mm . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 65.319999999999993 111.149 179.909 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.5 ttpp . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.814 0.34 . . . . 72.450000000000003 110.92 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.4 t -88.08 134.94 26.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 61.329999999999998 111.147 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -99.53 160.6 27.0 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.653 0.74 . . . . 71.420000000000002 110.944 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -20.06 35.3 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.715 2.276 . . . . 62.299999999999997 112.297 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -68.02 -19.73 64.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 32.399999999999999 110.887 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.14 6.16 37.01 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.742 -0.742 . . . . 71.409999999999997 112.455 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.2 t -115.87 168.7 9.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.868 0.366 . . . . 73.540000000000006 110.874 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 62.4 mt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 74.400000000000006 111.064 179.978 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.6 mtpt . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.849 0.357 . . . . 74.340000000000003 110.924 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.5 t -90.58 131.42 37.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 74.049999999999997 111.178 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -99.76 160.65 26.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.738 0.78 . . . . 75.430000000000007 110.928 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 -19.83 35.24 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.67 2.247 . . . . 75.040000000000006 112.37 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -68.11 -19.67 64.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 73.409999999999997 110.86 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.08 6.16 37.16 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.805 -0.712 . . . . 60.119999999999997 112.458 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 t -116.0 168.67 9.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.87 0.367 . . . . 73.0 110.817 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 58.4 mt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.089 -0.505 . . . . 74.409999999999997 111.111 179.927 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.873 0.368 . . . . 75.219999999999999 110.911 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.8 p -87.77 131.06 36.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.207 -0.451 . . . . 74.409999999999997 111.143 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -99.65 160.56 27.06 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.661 0.744 . . . . 63.310000000000002 110.908 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.85 -19.45 35.69 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.629 2.219 . . . . 70.430000000000007 112.299 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -68.73 -19.62 64.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.246 -0.434 . . . . 65.310000000000002 110.845 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.13 6.07 37.13 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.665 -0.779 . . . . 50.310000000000002 112.514 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 t -116.4 169.93 8.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.361 . . . . 71.230000000000004 110.935 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 16.3 pt . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.17 -0.468 . . . . 71.439999999999998 111.176 179.962 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 11.1 tptm . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.764 0.316 . . . . 73.219999999999999 110.916 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.2 t -90.89 129.26 41.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 63.119999999999997 111.147 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -98.58 160.5 27.85 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.762 0.791 . . . . 74.049999999999997 110.878 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -19.59 35.95 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.748 2.299 . . . . 62.32 112.354 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -69.04 -19.59 64.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.456 . . . . 71.329999999999998 110.798 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.11 6.0 37.26 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.701 -0.761 . . . . 71.400000000000006 112.457 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.6 t -115.57 169.03 9.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.9 0.381 . . . . 61.109999999999999 110.869 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.0 mp . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 62.520000000000003 111.164 179.935 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.857 0.36 . . . . 63.109999999999999 110.884 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.4 p -87.51 132.45 32.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.445 . . . . 64.530000000000001 111.15 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -99.04 160.53 27.47 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.668 0.747 . . . . 73.329999999999998 110.891 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -19.46 36.24 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.657 2.238 . . . . 74.319999999999993 112.344 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -68.89 -19.53 64.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.254 -0.43 . . . . 72.409999999999997 110.834 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.04 6.11 37.34 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.725 -0.75 . . . . 41.130000000000003 112.522 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 t -115.81 168.65 9.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.88 0.372 . . . . 73.129999999999995 110.832 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 41.8 mm . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 74.040000000000006 111.115 179.976 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.813 0.339 . . . . 62.130000000000003 110.915 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.6 p -97.53 134.3 36.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 72.420000000000002 111.099 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -99.98 160.6 26.77 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.705 0.764 . . . . 75.319999999999993 110.91 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -19.88 35.5 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.684 2.256 . . . . 73.109999999999999 112.335 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -68.05 -19.6 64.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 61.399999999999999 110.842 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.19 5.98 37.07 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.696 -0.764 . . . . 60.340000000000003 112.475 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.0 t -115.07 167.09 11.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.852 0.358 . . . . 64.430000000000007 110.876 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 62.8 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.484 . . . . 74.340000000000003 111.091 179.905 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.827 0.346 . . . . 73.409999999999997 110.889 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.4 t -95.03 131.42 41.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.445 . . . . 63.210000000000001 111.159 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -99.48 160.63 26.95 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.597 0.713 . . . . 74.209999999999994 110.975 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.85 -20.08 34.88 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.733 2.289 . . . . 61.229999999999997 112.312 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -68.25 -19.56 64.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 71.239999999999995 110.843 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.06 6.17 37.21 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.781 -0.724 . . . . 74.430000000000007 112.49 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 t -114.65 167.01 11.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.858 0.361 . . . . 64.239999999999995 110.871 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.5 mp . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.46 . . . . 71.150000000000006 111.141 179.905 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.824 0.345 . . . . 75.510000000000005 110.943 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.407 HG22 HD12 ' A' ' 12' ' ' ILE . 22.0 t -90.42 132.11 35.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 44.0 111.1 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -98.03 160.54 28.13 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.697 0.761 . . . . 61.299999999999997 110.939 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 -20.89 34.19 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.735 2.29 . . . . 74.129999999999995 112.364 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -68.19 -19.55 64.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 71.109999999999999 110.881 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.12 6.07 37.16 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.719 -0.753 . . . . 43.119999999999997 112.438 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.6 t -114.19 168.08 10.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.91 0.386 . . . . 71.019999999999996 110.867 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.407 HD12 HG22 ' A' ' 6' ' ' VAL . 25.3 mm . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.119 -0.492 . . . . 64.5 111.102 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.5 ttmm . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.867 0.365 . . . . 70.340000000000003 110.881 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.9 p -102.35 131.31 50.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 63.439999999999998 111.163 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -98.35 160.5 28.01 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.632 0.729 . . . . 74.420000000000002 110.962 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -20.19 35.25 Favored 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.696 2.264 . . . . 71.109999999999999 112.417 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -68.6 -19.42 64.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 74.129999999999995 110.901 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.07 6.11 37.26 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.743 -0.741 . . . . 73.319999999999993 112.489 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.5 t -114.62 167.32 10.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.842 0.353 . . . . 71.319999999999993 110.817 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.1 pt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 74.430000000000007 111.178 179.915 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.9 ttmt . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.809 0.338 . . . . 53.530000000000001 110.89 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.7 p -89.12 129.98 39.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 64.219999999999999 111.111 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -99.72 160.56 27.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.684 0.754 . . . . 71.340000000000003 110.95 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -19.89 35.66 Favored 'Trans proline' 0 C--N 1.34 0.115 0 C-N-CA 122.69 2.26 . . . . 74.329999999999998 112.335 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -68.34 -19.45 64.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 60.009999999999998 110.842 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.09 6.14 37.16 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 73.310000000000002 112.45 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.6 t -114.87 166.68 11.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.824 0.345 . . . . 50.420000000000002 110.859 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.6 mp . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 70.049999999999997 111.134 179.959 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 52.0 mttt . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.779 0.323 . . . . 71.319999999999993 110.913 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -94.57 131.34 41.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 72.209999999999994 111.146 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -99.69 160.66 26.76 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.707 0.765 . . . . 71.329999999999998 110.934 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.84 -19.29 35.93 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.658 2.239 . . . . 74.239999999999995 112.367 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -68.56 -19.47 64.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 63.210000000000001 110.939 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.06 6.12 37.26 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.779 -0.724 . . . . 65.109999999999999 112.523 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.2 t -114.28 164.62 13.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.915 0.388 . . . . 74.219999999999999 110.777 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.2 mp . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 74.540000000000006 111.097 179.958 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.4 mttp . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.834 0.35 . . . . 73.329999999999998 110.919 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.4 t -92.96 132.4 37.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 74.219999999999999 111.1 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -99.74 160.57 26.98 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.618 0.723 . . . . 75.040000000000006 110.965 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -19.98 35.53 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.653 2.235 . . . . 73.519999999999996 112.292 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 -68.09 -19.53 64.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 63.310000000000002 110.852 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.16 6.12 36.98 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 64.030000000000001 112.453 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 t -113.78 164.76 13.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.798 0.333 . . . . 73.329999999999998 110.85 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 55.6 mt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 75.129999999999995 111.112 179.937 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 31.3 tttt . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.823 0.345 . . . . 73.219999999999999 110.944 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -105.22 132.79 51.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 75.409999999999997 111.106 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -99.98 160.6 26.77 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.656 0.741 . . . . 74.030000000000001 110.953 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 -19.77 35.41 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.697 2.265 . . . . 74.439999999999998 112.322 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -68.04 -19.47 64.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 74.340000000000003 110.939 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.06 6.09 37.29 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.778 -0.725 . . . . 71.519999999999996 112.504 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 t -114.39 165.32 12.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.898 0.38 . . . . 73.450000000000003 110.815 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 29.0 pt . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.123 -0.489 . . . . 62.130000000000003 111.05 179.987 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.834 0.35 . . . . 74.230000000000004 110.905 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.9 p -97.32 136.74 27.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.295 -0.411 . . . . 75.439999999999998 111.147 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -100.0 160.59 26.8 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.717 0.77 . . . . 75.109999999999999 110.922 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -19.77 35.81 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.642 2.228 . . . . 71.120000000000005 112.411 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -68.06 -19.5 64.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 74.430000000000007 110.877 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.12 6.0 37.23 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.747 -0.739 . . . . 71.299999999999997 112.531 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.9 t -113.8 164.28 13.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.876 0.37 . . . . 30.41 110.836 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 31.6 mt . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 75.129999999999995 111.135 179.969 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.838 0.351 . . . . 64.329999999999998 110.829 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 11.4 m -129.21 162.13 28.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 63.350000000000001 110.934 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.5 tppt? -142.16 123.48 14.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 73.019999999999996 110.889 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -59.19 133.15 55.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 55.109999999999999 110.86 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -88.68 127.21 35.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.457 . . . . 71.510000000000005 110.954 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.5 p -93.73 130.85 42.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.26 -0.427 . . . . 71.040000000000006 111.134 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -99.26 160.5 27.42 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.627 0.727 . . . . 72.219999999999999 110.925 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -19.53 36.0 Favored 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.697 2.264 . . . . 73.030000000000001 112.376 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -68.63 -19.65 64.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 60.109999999999999 110.924 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.21 6.01 36.98 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.716 -0.754 . . . . 70.340000000000003 112.512 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 t -116.1 168.97 9.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.866 0.365 . . . . 62.409999999999997 110.851 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 23.0 pt -115.54 148.3 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.068 -0.515 . . . . 74.439999999999998 111.087 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.0 t -99.12 133.87 42.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.481 . . . . 62.539999999999999 110.839 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -99.17 61.06 1.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 71.519999999999996 110.866 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -148.13 116.88 6.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 74.0 110.904 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.1 t -113.13 144.61 42.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 63.039999999999999 110.902 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -87.18 133.68 33.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 73.319999999999993 110.857 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 13.7 p90 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 71.430000000000007 110.859 -179.802 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.6 t70 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.846 0.355 . . . . 63.240000000000002 110.848 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 5.8 t -129.19 150.14 50.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 73.030000000000001 110.887 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -113.68 114.9 27.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 72.5 110.833 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -58.94 128.63 38.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 75.150000000000006 110.829 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.4 mtpt -91.22 122.19 33.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 75.120000000000005 110.886 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -83.13 125.26 40.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 72.549999999999997 111.15 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -97.95 160.51 28.27 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.67 0.748 . . . . 74.310000000000002 110.919 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 -18.99 37.15 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.705 2.27 . . . . 70.530000000000001 112.354 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -70.17 -19.68 63.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 63.530000000000001 110.873 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.1 6.1 37.18 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.726 -0.749 . . . . 74.549999999999997 112.476 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 t -117.79 173.73 6.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.892 0.377 . . . . 45.0 110.813 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 20.4 pt -108.87 154.84 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 71.030000000000001 111.119 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 t -63.04 136.66 57.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 64.340000000000003 110.819 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -106.72 51.91 0.73 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.08 -0.509 . . . . 71.349999999999994 110.855 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -164.88 142.47 6.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 70.150000000000006 110.891 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 m -147.02 139.2 24.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.106 -0.497 . . . . 74.120000000000005 110.86 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -130.78 148.58 52.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 75.310000000000002 110.929 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 72.340000000000003 110.889 -179.89 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.838 0.351 . . . . 75.329999999999998 110.856 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 45.2 t -134.15 140.11 46.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 73.219999999999999 110.858 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -81.45 120.09 24.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.125 -0.489 . . . . 45.409999999999997 110.89 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 35.0 ptt85 -54.01 137.62 39.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 72.329999999999998 110.888 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -99.13 114.22 26.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 71.230000000000004 110.901 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.5 t -76.96 124.53 35.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 73.150000000000006 111.159 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -98.16 160.6 27.91 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.673 0.749 . . . . 72.519999999999996 110.879 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -19.01 36.7 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.716 2.277 . . . . 54.549999999999997 112.259 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -69.78 -19.64 63.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.427 . . . . 72.129999999999995 110.901 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.09 6.13 37.17 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.744 -0.741 . . . . 71.400000000000006 112.52 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 t -117.14 171.57 7.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.9 0.381 . . . . 64.340000000000003 110.818 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 21.9 pt -110.92 140.87 28.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 72.200000000000003 111.114 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.3 t -61.71 176.93 0.46 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 53.310000000000002 110.851 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -134.08 -43.84 0.79 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.501 . . . . 74.5 110.886 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -89.0 147.34 24.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 71.019999999999996 110.98 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 82.9 m -121.29 166.62 13.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 75.230000000000004 110.879 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -105.27 136.98 43.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 62.240000000000002 110.886 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 62.130000000000003 110.952 -179.903 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.798 0.332 . . . . 75.420000000000002 110.86 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 30.9 p -116.57 157.45 25.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 72.120000000000005 110.922 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.43 148.54 52.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 71.409999999999997 110.85 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 53.3 mtt85 -60.3 157.0 14.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 53.109999999999999 110.844 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.7 tttp -129.97 130.65 45.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 60.350000000000001 110.964 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.8 t -88.44 129.18 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 65.439999999999998 111.179 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -98.97 160.6 27.32 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.707 0.765 . . . . 74.239999999999995 110.906 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -19.03 36.62 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.657 2.238 . . . . 64.010000000000005 112.373 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -69.32 -19.61 63.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 75.319999999999993 110.827 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.05 6.1 37.31 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.73 -0.748 . . . . 64.239999999999995 112.479 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.2 t -117.15 171.08 8.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.854 0.359 . . . . 53.420000000000002 110.853 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.8 mp -115.06 140.6 35.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 53.5 111.113 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.0 t -79.29 129.95 34.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 75.129999999999995 110.864 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -116.43 74.05 0.88 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.123 -0.489 . . . . 52.240000000000002 110.904 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -150.27 131.95 14.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.15 -0.477 . . . . 75.140000000000001 110.953 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 27.9 t -135.77 149.61 49.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 61.539999999999999 110.903 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -88.35 147.18 24.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 64.099999999999994 110.865 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 17.6 p90 . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 75.340000000000003 110.91 -179.879 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 . . . . . 0 C--O 1.232 0.171 0 CA-C-O 120.827 0.346 . . . . 75.310000000000002 110.888 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 43.7 t -137.07 143.57 42.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 75.219999999999999 110.906 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -72.75 140.35 47.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 74.200000000000003 110.978 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.56 130.17 55.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.314 -0.403 . . . . 72.420000000000002 110.871 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.22 122.17 23.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.261 -0.427 . . . . 75.25 110.909 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p -88.3 128.76 40.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.439 . . . . 53.299999999999997 111.087 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -99.1 160.65 27.13 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.623 0.725 . . . . 74.239999999999995 110.927 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 -19.08 36.22 Favored 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.651 2.234 . . . . 71.319999999999993 112.337 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -69.21 -19.69 63.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 40.32 110.87 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.15 6.08 37.06 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.77 -0.729 . . . . 72.450000000000003 112.48 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.2 t -117.13 171.11 8.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.853 0.358 . . . . 74.129999999999995 110.878 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 17.0 pt -112.29 154.17 13.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 73.340000000000003 111.096 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 t -56.89 178.58 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 72.439999999999998 110.867 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -111.69 -34.68 5.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 72.340000000000003 110.864 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -127.6 142.15 51.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.195 -0.457 . . . . 62.240000000000002 110.906 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.0 p -127.32 152.79 47.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 64.310000000000002 110.876 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -141.69 152.59 44.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 61.539999999999999 110.932 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 74.9 t80 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.178 -0.464 . . . . 74.239999999999995 110.974 -179.86 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.0 t70 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.886 0.374 . . . . 64.409999999999997 110.831 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 10.6 t -115.05 138.2 51.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 71.439999999999998 110.893 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -63.88 131.55 48.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 64.299999999999997 110.879 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.29 170.19 10.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 73.439999999999998 110.858 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -135.97 142.76 44.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.192 -0.458 . . . . 75.430000000000007 110.924 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.3 t -88.02 134.12 28.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 71.430000000000007 111.087 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -97.98 160.61 27.99 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.693 0.759 . . . . 73.200000000000003 110.947 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.74 -18.71 36.96 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.706 2.271 . . . . 73.340000000000003 112.37 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -70.13 -19.65 63.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 75.109999999999999 110.925 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.13 6.08 37.12 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.697 -0.763 . . . . 75.310000000000002 112.504 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.7 t -116.06 169.11 9.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.811 0.338 . . . . 55.299999999999997 110.845 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 25.7 mm -102.04 144.38 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 65.319999999999993 111.149 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.1 p -58.42 147.02 32.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.086 -0.507 . . . . 61.25 110.905 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.44 41.93 3.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 64.430000000000007 110.912 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -143.51 153.4 42.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.435 . . . . 72.450000000000003 110.96 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.6 m -130.41 155.57 46.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 63.25 110.818 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -107.02 146.27 31.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.505 . . . . 64.510000000000005 110.885 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 6.7 t80 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 75.299999999999997 110.919 -179.88 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.846 0.355 . . . . 72.5 110.875 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 13.3 m -122.62 149.96 43.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 72.340000000000003 110.851 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.8 mttm -146.01 149.77 34.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 72.319999999999993 110.96 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -59.35 154.57 16.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 74.019999999999996 110.931 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.5 ttpp -138.46 131.84 30.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 72.450000000000003 110.92 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.4 t -88.08 134.94 26.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 61.329999999999998 111.147 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -99.53 160.6 27.0 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.653 0.74 . . . . 71.420000000000002 110.944 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -20.06 35.3 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.715 2.276 . . . . 62.299999999999997 112.297 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -68.02 -19.73 64.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 32.399999999999999 110.887 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.14 6.16 37.01 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.742 -0.742 . . . . 71.409999999999997 112.455 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.2 t -115.87 168.7 9.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.868 0.366 . . . . 73.540000000000006 110.874 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 62.4 mt -109.41 142.49 21.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 74.400000000000006 111.064 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.0 p -70.05 160.81 31.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 62.119999999999997 110.869 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -109.16 -43.76 4.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 71.109999999999999 110.903 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -105.19 166.91 10.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.087 -0.506 . . . . 74.129999999999995 110.951 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.1 p -114.77 154.48 28.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.115 -0.493 . . . . 61.420000000000002 110.904 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -139.75 143.06 36.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 72.519999999999996 110.909 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 70.7 t80 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.154 -0.475 . . . . 72.129999999999995 110.916 -179.84 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.863 0.363 . . . . 72.420000000000002 110.866 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 47.8 t -125.51 146.07 49.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 74.239999999999995 110.836 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 48.0 tttp -69.22 117.2 10.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 74.219999999999999 110.943 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -91.69 170.98 9.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 74.549999999999997 110.81 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.6 mtpt -123.94 135.15 53.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 74.340000000000003 110.924 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.5 t -90.58 131.42 37.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 74.049999999999997 111.178 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -99.76 160.65 26.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.738 0.78 . . . . 75.430000000000007 110.928 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 -19.83 35.24 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.67 2.247 . . . . 75.040000000000006 112.37 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -68.11 -19.67 64.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 73.409999999999997 110.86 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.08 6.16 37.16 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.805 -0.712 . . . . 60.119999999999997 112.458 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 t -116.0 168.67 9.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.87 0.367 . . . . 73.0 110.817 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 58.4 mt -115.95 143.53 25.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.089 -0.505 . . . . 74.409999999999997 111.111 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.5 t -58.4 149.01 25.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 73.209999999999994 110.901 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -92.38 -43.27 9.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 63.520000000000003 110.884 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -109.36 154.11 23.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 73.140000000000001 110.956 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.0 p -122.6 143.3 49.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 44.130000000000003 110.882 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -132.09 129.47 39.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 53.43 110.869 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 75.6 t80 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.104 -0.498 . . . . 73.340000000000003 110.889 -179.812 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.903 0.383 . . . . 65.430000000000007 110.877 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 2.7 m -118.39 167.91 11.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 74.129999999999995 110.847 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.84 120.71 11.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 73.329999999999998 110.884 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.5 ptp85 -52.51 103.44 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 72.230000000000004 110.85 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt -68.85 111.18 4.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 75.219999999999999 110.911 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.8 p -87.77 131.06 36.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.207 -0.451 . . . . 74.409999999999997 111.143 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -99.65 160.56 27.06 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.661 0.744 . . . . 63.310000000000002 110.908 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.85 -19.45 35.69 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.629 2.219 . . . . 70.430000000000007 112.299 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -68.73 -19.62 64.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.246 -0.434 . . . . 65.310000000000002 110.845 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.13 6.07 37.13 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.665 -0.779 . . . . 50.310000000000002 112.514 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 t -116.4 169.93 8.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.361 . . . . 71.230000000000004 110.935 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 16.3 pt -112.79 149.83 15.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.17 -0.468 . . . . 71.439999999999998 111.176 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.5 m -74.89 -177.0 3.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.295 -0.411 . . . . 70.099999999999994 110.841 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -118.48 -65.72 1.15 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.042 -0.526 . . . . 74.299999999999997 110.884 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -75.73 140.08 42.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.229 -0.441 . . . . 72.030000000000001 110.932 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 22.1 p -120.75 139.59 52.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 61.0 110.839 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -86.37 146.13 26.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.481 . . . . 71.319999999999993 110.899 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 33.2 p90 . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 64.519999999999996 110.967 -179.951 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 24.1 t0 . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.825 0.345 . . . . 64.420000000000002 110.811 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 63.4 m -133.88 144.33 48.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.448 . . . . 63.43 110.894 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.08 123.54 50.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 73.140000000000001 110.901 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 85.2 mtm-85 -88.23 98.93 11.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 71.549999999999997 110.883 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 11.1 tptm -95.28 128.97 42.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.45 . . . . 73.219999999999999 110.916 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.2 t -90.89 129.26 41.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 63.119999999999997 111.147 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -98.58 160.5 27.85 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.762 0.791 . . . . 74.049999999999997 110.878 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -19.59 35.95 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.748 2.299 . . . . 62.32 112.354 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -69.04 -19.59 64.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.456 . . . . 71.329999999999998 110.798 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.11 6.0 37.26 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.701 -0.761 . . . . 71.400000000000006 112.457 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.6 t -115.57 169.03 9.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.9 0.381 . . . . 61.109999999999999 110.869 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.0 mp -113.24 149.84 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 62.520000000000003 111.164 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.7 t -93.02 143.32 26.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 71.099999999999994 110.882 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -113.95 64.52 0.66 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.177 -0.465 . . . . 63.140000000000001 110.848 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -100.31 134.83 42.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 73.310000000000002 110.944 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 98.4 m -131.34 144.22 51.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.086 -0.506 . . . . 52.549999999999997 110.891 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -106.29 152.61 23.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.459 . . . . 75.239999999999995 110.854 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 52.5 t80 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 74.329999999999998 110.942 -179.869 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.81 0.338 . . . . 71.319999999999993 110.89 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 29.0 p -138.93 149.54 44.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 63.520000000000003 110.882 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.8 mmtm -108.95 139.37 43.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.225 -0.443 . . . . 61.240000000000002 110.864 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -65.2 140.2 58.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 74.439999999999998 110.869 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? -103.87 124.89 49.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 63.109999999999999 110.884 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.4 p -87.51 132.45 32.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.445 . . . . 64.530000000000001 111.15 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -99.04 160.53 27.47 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.668 0.747 . . . . 73.329999999999998 110.891 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -19.46 36.24 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.657 2.238 . . . . 74.319999999999993 112.344 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -68.89 -19.53 64.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.254 -0.43 . . . . 72.409999999999997 110.834 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.04 6.11 37.34 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.725 -0.75 . . . . 41.130000000000003 112.522 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 t -115.81 168.65 9.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.88 0.372 . . . . 73.129999999999995 110.832 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 41.8 mm -111.26 145.85 16.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 74.040000000000006 111.115 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.7 t -81.69 146.69 29.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 64.319999999999993 110.904 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -114.89 41.45 2.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 73.239999999999995 110.862 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -122.42 147.56 46.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 71.209999999999994 110.958 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.8 m -141.47 147.86 38.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 70.209999999999994 110.865 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -106.69 121.11 43.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 63.229999999999997 110.866 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 41.3 p90 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 70.150000000000006 110.89 -179.843 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.883 0.373 . . . . 74.310000000000002 110.933 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 35.3 m -126.85 156.04 41.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 74.430000000000007 110.898 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 43.4 mmtt -112.09 137.41 50.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 72.239999999999995 110.924 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.5 ppt_? -74.76 167.6 21.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.42 . . . . 75.540000000000006 110.874 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -146.24 153.19 40.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 62.130000000000003 110.915 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.6 p -97.53 134.3 36.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 72.420000000000002 111.099 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -99.98 160.6 26.77 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.705 0.764 . . . . 75.319999999999993 110.91 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -19.88 35.5 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.684 2.256 . . . . 73.109999999999999 112.335 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -68.05 -19.6 64.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 61.399999999999999 110.842 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.19 5.98 37.07 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.696 -0.764 . . . . 60.340000000000003 112.475 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.0 t -115.07 167.09 11.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.852 0.358 . . . . 64.430000000000007 110.876 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 62.8 mt -114.57 144.8 21.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.484 . . . . 74.340000000000003 111.091 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.3 t -82.21 140.96 33.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 22.219999999999999 110.871 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -113.64 -31.48 6.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 53.299999999999997 110.902 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -84.98 159.64 20.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.212 -0.449 . . . . 73.510000000000005 110.917 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 36.5 t -124.94 131.5 53.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 73.150000000000006 110.896 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -121.33 152.54 38.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 72.530000000000001 110.904 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 50.3 p90 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.21 -0.45 . . . . 74.430000000000007 110.891 -179.966 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.84 0.352 . . . . 74.230000000000004 110.819 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 1.8 m -122.49 169.91 10.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.09 -0.505 . . . . 74.109999999999999 110.821 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.1 tttp -70.24 135.38 48.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.497 . . . . 61.530000000000001 110.938 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -107.93 144.02 35.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 55.130000000000003 110.875 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 27.4 ttmt -118.09 126.39 52.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 73.409999999999997 110.889 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.4 t -95.03 131.42 41.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.445 . . . . 63.210000000000001 111.159 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -99.48 160.63 26.95 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.597 0.713 . . . . 74.209999999999994 110.975 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.85 -20.08 34.88 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.733 2.289 . . . . 61.229999999999997 112.312 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -68.25 -19.56 64.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 71.239999999999995 110.843 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.06 6.17 37.21 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.781 -0.724 . . . . 74.430000000000007 112.49 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 t -114.65 167.01 11.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.858 0.361 . . . . 64.239999999999995 110.871 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.5 mp -117.28 145.47 23.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.46 . . . . 71.150000000000006 111.141 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.6 t -104.27 134.3 47.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 74.409999999999997 110.814 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -109.29 88.54 2.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.061 -0.518 . . . . 73.019999999999996 110.845 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -141.78 127.18 18.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 71.109999999999999 110.908 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.9 t -116.43 140.32 49.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 74.019999999999996 110.824 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -73.85 151.19 40.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 71.319999999999993 110.822 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 44.5 p90 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.144 -0.48 . . . . 74.409999999999997 110.933 -179.905 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.809 0.337 . . . . 74.319999999999993 110.91 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 16.6 t -132.37 144.26 50.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 62.340000000000003 110.836 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -79.19 148.56 32.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 74.219999999999999 110.927 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.12 137.26 48.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 71.219999999999999 110.912 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -125.8 133.37 52.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 75.510000000000005 110.943 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.407 HG22 HD12 ' A' ' 12' ' ' ILE . 22.0 t -90.42 132.11 35.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 44.0 111.1 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -98.03 160.54 28.13 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.697 0.761 . . . . 61.299999999999997 110.939 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 -20.89 34.19 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.735 2.29 . . . . 74.129999999999995 112.364 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -68.19 -19.55 64.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 71.109999999999999 110.881 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.12 6.07 37.16 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.719 -0.753 . . . . 43.119999999999997 112.438 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.6 t -114.19 168.08 10.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.91 0.386 . . . . 71.019999999999996 110.867 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.407 HD12 HG22 ' A' ' 6' ' ' VAL . 25.3 mm -107.82 146.26 14.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.119 -0.492 . . . . 64.5 111.102 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.5 m -67.34 121.08 14.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 70.219999999999999 110.832 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -91.61 -41.62 10.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.116 -0.493 . . . . 64.239999999999995 110.841 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -71.21 166.42 21.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 73.319999999999993 110.951 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 92.3 m -124.4 134.34 53.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.139 -0.482 . . . . 75.430000000000007 110.945 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -96.27 140.07 31.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 73.420000000000002 110.871 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.113 -0.494 . . . . 70.319999999999993 110.905 -179.86 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 34.3 t70 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.883 0.373 . . . . 63.130000000000003 110.92 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 44.0 t -150.43 134.75 17.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.437 . . . . 73.230000000000004 110.885 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -72.81 144.98 47.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 74.310000000000002 110.95 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 88.0 mtt180 -57.3 115.73 2.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 75.310000000000002 110.839 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.5 ttmm -67.22 133.03 48.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 70.340000000000003 110.881 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.9 p -102.35 131.31 50.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 63.439999999999998 111.163 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -98.35 160.5 28.01 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.632 0.729 . . . . 74.420000000000002 110.962 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -20.19 35.25 Favored 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.696 2.264 . . . . 71.109999999999999 112.417 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -68.6 -19.42 64.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 74.129999999999995 110.901 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.07 6.11 37.26 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.743 -0.741 . . . . 73.319999999999993 112.489 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.5 t -114.62 167.32 10.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.842 0.353 . . . . 71.319999999999993 110.817 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.1 pt -111.87 153.13 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 74.430000000000007 111.178 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.8 t -70.61 161.81 30.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 61.340000000000003 110.849 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -81.07 -53.12 6.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 74.430000000000007 110.827 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -136.2 174.63 10.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 72.230000000000004 110.874 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 13.9 t -121.79 125.89 47.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 74.430000000000007 110.849 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -68.15 145.06 54.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.096 -0.502 . . . . 64.150000000000006 110.919 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 13.1 t80 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.092 -0.504 . . . . 72.340000000000003 110.935 -179.851 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.857 0.36 . . . . 63.109999999999999 110.86 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 12.1 t -130.35 152.46 49.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 75.409999999999997 110.862 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -80.53 111.57 17.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 64.400000000000006 110.894 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.95 147.49 7.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 72.230000000000004 110.88 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.9 ttmt -105.26 115.33 30.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 53.530000000000001 110.89 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.7 p -89.12 129.98 39.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 64.219999999999999 111.111 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -99.72 160.56 27.03 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.684 0.754 . . . . 71.340000000000003 110.95 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -19.89 35.66 Favored 'Trans proline' 0 C--N 1.34 0.115 0 C-N-CA 122.69 2.26 . . . . 74.329999999999998 112.335 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -68.34 -19.45 64.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 60.009999999999998 110.842 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.09 6.14 37.16 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 73.310000000000002 112.45 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.6 t -114.87 166.68 11.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.824 0.345 . . . . 50.420000000000002 110.859 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.6 mp -118.45 138.26 49.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 70.049999999999997 111.134 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.3 t -94.78 128.12 41.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 32.210000000000001 110.873 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -93.66 60.3 2.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.486 . . . . 70.0 110.839 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -137.44 152.76 49.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 75.310000000000002 110.921 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 16.3 t -135.21 129.99 34.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 71.519999999999996 110.895 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -61.82 137.19 58.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 63.329999999999998 110.796 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 36.9 p90 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 74.430000000000007 110.996 -179.92 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 . . . . . 0 N--CA 1.457 -0.093 0 CA-C-O 120.86 0.362 . . . . 64.329999999999998 110.905 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 34.9 m -122.96 145.29 48.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 71.319999999999993 110.895 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -81.18 126.36 31.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.465 . . . . 64.439999999999998 110.875 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -88.12 131.85 34.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.291 -0.413 . . . . 65.219999999999999 110.889 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -138.82 137.16 36.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 71.319999999999993 110.913 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -94.57 131.34 41.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 72.209999999999994 111.146 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -99.69 160.66 26.76 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.707 0.765 . . . . 71.329999999999998 110.934 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.84 -19.29 35.93 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.658 2.239 . . . . 74.239999999999995 112.367 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -68.56 -19.47 64.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 63.210000000000001 110.939 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.06 6.12 37.26 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.779 -0.724 . . . . 65.109999999999999 112.523 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.2 t -114.28 164.62 13.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.915 0.388 . . . . 74.219999999999999 110.777 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.2 mp -119.25 143.23 31.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 74.540000000000006 111.097 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.4 m -69.75 116.74 10.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 73.349999999999994 110.807 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -83.61 -64.63 1.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.081 -0.509 . . . . 62.520000000000003 110.827 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -89.6 156.86 18.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 72.409999999999997 110.912 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.7 p -118.3 144.4 45.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 55.420000000000002 110.94 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -77.76 143.49 37.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 74.310000000000002 110.961 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 33.4 p90 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 71.420000000000002 110.886 -179.799 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.861 0.362 . . . . 61.039999999999999 110.826 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 7.5 p -119.91 159.48 24.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 61.420000000000002 110.848 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -63.17 122.7 16.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 75.409999999999997 110.875 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -69.56 110.53 4.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 62.329999999999998 110.873 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.4 mttp -76.95 116.73 17.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 73.329999999999998 110.919 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.4 t -92.96 132.4 37.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 74.219999999999999 111.1 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -99.74 160.57 26.98 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.618 0.723 . . . . 75.040000000000006 110.965 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -19.98 35.53 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.653 2.235 . . . . 73.519999999999996 112.292 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 -68.09 -19.53 64.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 63.310000000000002 110.852 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.16 6.12 36.98 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 64.030000000000001 112.453 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 t -113.78 164.76 13.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.798 0.333 . . . . 73.329999999999998 110.85 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 55.6 mt -117.64 144.07 26.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 75.129999999999995 111.112 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 m -103.0 129.46 49.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.482 . . . . 75.129999999999995 110.863 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -110.8 39.03 2.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.078 -0.51 . . . . 72.209999999999994 110.832 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -120.86 103.99 9.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.45 . . . . 55.100000000000001 110.916 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.1 p -127.22 130.78 50.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 73.430000000000007 110.867 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -63.04 125.15 23.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.104 -0.498 . . . . 62.140000000000001 110.889 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.6 p90 . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 116.179 -0.464 . . . . 62.009999999999998 110.969 -179.897 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.85 0.357 . . . . 61.350000000000001 110.822 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 24.5 m -140.79 144.54 35.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 62.130000000000003 110.857 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.5 ptmm? -114.52 127.85 56.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 63.219999999999999 110.877 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 86.2 mtm180 -74.76 119.51 19.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 73.340000000000003 110.902 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 31.3 tttt -69.12 142.28 54.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.44 . . . . 73.219999999999999 110.944 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -105.22 132.79 51.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 75.409999999999997 111.106 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -99.98 160.6 26.77 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.656 0.741 . . . . 74.030000000000001 110.953 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 -19.77 35.41 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.697 2.265 . . . . 74.439999999999998 112.322 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -68.04 -19.47 64.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 74.340000000000003 110.939 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.06 6.09 37.29 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.778 -0.725 . . . . 71.519999999999996 112.504 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 t -114.39 165.32 12.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.898 0.38 . . . . 73.450000000000003 110.815 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 29.0 pt -116.24 156.14 17.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.123 -0.489 . . . . 62.130000000000003 111.05 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 27.3 t -121.38 167.36 12.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.139 -0.482 . . . . 74.230000000000004 110.933 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -112.34 91.3 3.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.179 -0.464 . . . . 73.530000000000001 110.798 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -130.89 154.14 48.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 72.439999999999998 110.882 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 61.7 m -124.75 129.58 50.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.113 -0.494 . . . . 42.119999999999997 110.886 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -102.16 146.1 28.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 75.010000000000005 110.9 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.1 p90 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.234 -0.439 . . . . 75.25 110.92 -179.9 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.3 t70 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.871 0.367 . . . . 75.109999999999999 110.885 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 30.9 t -135.31 143.97 46.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 71.510000000000005 110.875 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -91.8 115.85 28.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 72.219999999999999 110.833 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 78.5 mtm-85 -59.65 131.36 50.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 74.140000000000001 110.839 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -105.9 132.22 52.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 74.230000000000004 110.905 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.9 p -97.32 136.74 27.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.295 -0.411 . . . . 75.439999999999998 111.147 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -100.0 160.59 26.8 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.717 0.77 . . . . 75.109999999999999 110.922 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -19.77 35.81 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.642 2.228 . . . . 71.120000000000005 112.411 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -68.06 -19.5 64.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 74.430000000000007 110.877 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.12 6.0 37.23 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.747 -0.739 . . . . 71.299999999999997 112.531 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.9 t -113.8 164.28 13.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.876 0.37 . . . . 30.41 110.836 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 31.6 mt -112.25 137.95 43.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 75.129999999999995 111.135 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.9 t -57.04 149.11 19.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 61.32 110.832 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -106.38 -38.22 6.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.511 . . . . 63.399999999999999 110.876 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -119.23 138.48 52.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 70.439999999999998 110.935 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 6.1 p -133.55 159.72 39.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.112 -0.495 . . . . 64.140000000000001 110.932 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -94.33 141.57 28.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 62.219999999999999 110.914 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 35.9 t80 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.143 -0.48 . . . . 72.519999999999996 110.933 -179.861 . . . . . . . . 0 0 . 1 stop_ save_